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 The increase of calcium in the cell can induce cellular functions such as fertilization, cell 
division and cell communication. Calcium (Ca
2+
) carries out these processes through proteins 
called calcium sensors.  An important calcium modulator is calmodulin.  Calmodulin has four 
possible Ca
2+
 binding sites that have the characteristic helix-loop-helix (EF hand) motif. When 
the EF hands bind to Ca
2+
, methionine rich hydrophobic patches are exposed allowing for CaM 
to interact with target proteins. However, there are proteins that can interact with CaM at low 
levels of Ca
2+
 or in the absence of Ca
2+
.   
 An enzyme that is activated by CaM is nitric oxide synthase (NOS), which converts L-
arginine to L-citrulline and nitric oxide (•NO), where •NO is used to carry out important cellular 
functions. There are three isoforms of the enzyme; endothelial, neuronal and inducible NOS.  
The first two isoforms are activated by Ca
2+





-dependent whereas inducible NOS (iNOS) is activated and binds tightly to CaM 
regardless of the Ca
2+
 concentration and is therefore Ca
2+
-independent. Of particular interest is 
the iNOS enzyme, since no three-dimensional structures of the reductase domain or the CaM-
binding region have been solved. 
 All three isoforms of NOS exist as homodimers, where each monomer consisting of a 
reductase domain and an oxygenase domain separated by a CaM-binding region. The reductase 
domain contains binding sites for NADPH and the flavins, FAD and FMN, which facilitate 
electron transfer from the NADPH to the catalytic heme in the oxygenase domain of the opposite 
monomer. The transfer of electrons from the FAD to the heme is carried out by the FMN domain 
which is proposed to swing between the two docking points since the distance between the two 





which is essential for NOS activation. This dynamic process and the direct role of CaM have yet 
to be observed structurally. A method to monitor dynamics structurally is through the use of 
nuclear magnetic resonance (NMR) spectroscopy. 
 Therefore as the first step to determine the NMR structure of the FMN domain with the 
CaM-binding region, the structure of the iNOS CaM-binding region bound to CaM will be 
determined. The structure will allow for further characterization and identification of important 
interactions between the iNOS CaM-binding region and CaM which contribute to the unique 
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Chapter 1 Introduction 
1.1 Calmodulin (CaM) 
 Calcium ions (Ca
2+
) are present in all cellular systems and are the most abundant mineral 
in the body where 99% of the total concentration is present in the bone and the other 1% is 
located in the bodily fluids and in cells (Duyff, 2006). Calcium in cells acts as a secondary 
messenger by controlling some of the most important biological functions, which include 
fertilization, cell proliferation including division, cell communication, neuron transmission and 
cell death (Duyff, 2006). These functions are regulated by a family of Ca
2+
-binding proteins that 
respond to changing intracellular Ca
2+
 concentrations.  These Ca
2+
-modulated proteins contain an 
EF hand motif which consists of a helix-loop-helix pattern where the calcium binds in the loop 
region (Figure 1.1). One of the most important proteins belonging to this family is calmodulin.  
 
Figure 1.1. Ribbon structure of the EF hand motif with Ca
2+
 binding amino acids 
The helix-loop-helix of the EF hand motif taken from the crystal structure of the third EF hand of 
CaM bound to Ca
2+
. The amino acids represented by the ball and stick figures contribute to the 
binding of Ca
2+
 ion (green sphere) through negatively charged oxygen (red sphere attached to 
green line). The distributions of Ca
2+
 coordinating amino acids have the 1-3-5-7-9-12 position 





Calmodulin (CaM) is an essential protein because it is able to respond to changing 
intracellular Ca
2+
 concentrations and the target proteins it activates are responsible for several 
vital cellular functions including cell division, apoptosis, blood pressure, fertilization, 
intracellular communication and cell differentiation (Frederick et al., 2006, Benaim and 
Villalobo, 2002).  It is a highly conserved small protein that consists of 148 amino acids and has 
a molecular weight of 17 kDa. CaM is present in most, if not all, eukaryotic cells and through its 
four EF hands, it binds to Ca
2+
 and is able to bind over a hundred proteins. 
1.1.1 Structure of CaM 
CaM has two globular regions referred to as the N- and C-terminal lobes which are 
separated by a highly flexible central linker region. In each lobe, there are two solvent exposed 
EF hand motifs that cooperatively bind to free Ca
2+
. The C-terminus EF hands bind to Ca
2+
 with 
a higher affinity than the N-terminus, allowing for different forms of Ca
2+
 saturated CaM. A 
nuclear magnetic resonance (NMR) structure of Ca
2+
-free (apo) CaM (Figure 1.2a) indicates that 
the two lobes move independently of each other due to the flexible central linker region, 
consisting of residue 77 to 81; and that the N-terminal lobe is a more resolved structure and not 


















a b c d 
Figure 1.2. Structural comparison of CaM in its calcium free and bound forms 
The structures of apo CaM and holo CaM in its ribbon structure and surface structure indicating 
hydrophobic patches are shown with the N-terminal domain as the top globular lobe and the C-
terminal domain in the lower globular lobe. (a) Three possible conformations of thirty of the 
Ca
2+
-free CaM determined by NMR spectroscopy show the N-terminal lobe remains in the same 
conformation whereas the C-terminal lobes are highly mobile. (b) The surface representation of 
hydrophobic patches (blue) of apo-CaM is mainly internalized compared to (d) that of the holo-
CaM. (c) The crystal structure of Ca
2+
 (yellow spheres) saturated calmodulin with the central 
region elongated. Structures were made from PDB 1DMO and 1CLL for Ca
2+
-free and bound 
respectively using Accelrys DS visualize 2.4.  
When CaM binds Ca
2+ 
(holo-CaM), the general secondary structure of the protein 
remains the same except that now the collapsed globular domains in the apo-CaM turn outwards 
to elongate the overall CaM structure to increase the distance between the domains (Babu et al., 
1988, Kuboniwa et al., 1995, Zhang et al., 1995).  During this conformational change, CaM 
exposes hydrophobic patches, which are larger in the C than the N-terminal lobe, (Figure 1.2d) 
allowing it to interact with its target proteins (Yamniuk and Vogel, 2004). The hydrophobic 
patches are enriched with nine methionines, four in each terminal domain and one in the centre 





other proteins, CaM has elevated levels of methionine which contributes to tight interaction with 
non-polar surfaces due to the thioether sulfur in the side chain to accommodate different non-
polar binding surfaces (Gellman, 1991). The main mode of interaction is through hydrophobic 
interactions and van der Waals forces but electrostatic interactions are also important (Yamniuk 
and Vogel, 2004). In addition to the methionine rich hydrophobic patches, the central linker 
region also plays an important role by unraveling from the α-helix into random coil (O'Neil and 
DeGardo, 1990). The ability of the central linker to extend allows for the two terminal lobes to 
accommodate binding of different target proteins. Despite the crystal structure of the Ca
2+
-CaM 
(Figure 1.2c) showing the centre linker as a rigid α-helix, NMR studies indicate the centre linker 
still remains very flexible and still allows for independent movement of the two domains 






-independent Calmodulin binding to Target Proteins 





based on whether the target proteins can bind to holo-CaM during an increase of intracellular 
Ca
2+





-dependent target proteins require Ca
2+
 bound CaM which occurs when Ca
2+
 
concentration is above the basal level. At resting Ca
2+
 levels the concentration of Ca
2+
 is 0.1 µM 
and can increase over one hundredfold to 10 µM (Roskoski, 1996, Van Eldik and Watterson, 
1998). The sequence of CaM-binding regions of Ca
2+
-dependent target protein varies, however 
they are typically 16-30 amino acids in length and are basic amphiphilic α-helical, containing 
bulky hydrophobic amino acids (Yamniuk and Vogel, 2004, O'Neil and DeGardo, 1990, Afshar 





on top of each other in the α-helix creating a parallel hydrophobic surface or, in some target 
proteins, a hydrophobic curved surface on the α-helix (O'Neil and DeGardo, 1990). The 
hydrophobic patches of CaM in the terminal lobes bind are shown to bind to bulky hydrophobic 
amino acids that are separated by 8 or 12 residues (Afshar et al., 1994). Typical bulky 
hydrophobic amino are the aromatic or long side chained nonpolar amino acids. The 
hydrophobic amino acids that bind to the hydrophobic patches of CaM are termed anchoring 
residues, these allow for other hydrophobic residues in between them to interact with CaM 
(Yamniuk and Vogel, 2004). Based on sequence alignment of Ca
2+
-dependent CaM-binding 
regions, conserved positions of bulky hydrophobic residues are arranged in a 1-8-14, 1-5-8-14 or 
1-5-10 motif; where the numbering system starts with the first hydrophobic residue and the two 
outer numbers represent the anchoring residues (Yamniuk and Vogel, 2004, Rhoads and 
Friedberg, 1997). Along with hydrophobic amino acids, target proteins also contain positively 
charged basic amino acids that give the CaM-binding regions their amphiphilic property. These 
basic residues are located on the opposite side of the hydrophobic patches in the α-helix and 
interact mainly with the central linker region of CaM, which is lined with negatively charged 
amino acid (O'Neil and DeGardo, 1990, Afshar et al., 1994). These residues account for the 
electrostatic interactions with CaM. There are variations in the binding motifs described above as 
well as target proteins that have a very different binding motif (Rhoads and Friedberg, 1997).   
Target proteins that are categorized as Ca
2+
-independent can bind to CaM in the absence 
of Ca
2+
 or at very low basal concentration of Ca
2+
. Included in this group of proteins are those 
that bind only to apo-CaM, such as neuromodulin, that are thought to act as an intracellular CaM 
storage protein until Ca
2+
 concentration increases (Jurado et al., 1999). The majority of proteins 
classified as Ca
2+





absence of CaM (Rhoads and Friedberg, 1997). A known sequence that binds to apo-CaM is the 
consensus IQ motif which has the general form IQXXXRGXXXR, where I, Q, R, G and X 
represent the amino acids isoleucine, glutamic acid, arginine, glycine and any amino acid 
respectively (Rhoads and Friedberg, 1997).  The isoleucine can be replaced with a leucine or 
valine and the X amino acid may also play a role in the binding (Jurado et al., 1999). The 
IQXXX portion interacts mainly with the more slightly open conformation of the C-terminal 
lobe of CaM leaving the other half to interact with the N-terminal lobe (Yamniuk and Vogel, 
2004). The IQ motif takes on an α-helical conformation that also interacts through hydrophobic 
and electrostatic interactions with small hydrophobic patches and negatively charged amino acid 
scattered on the surface of apo-CaM (Zhang et al., 1995). The IQ motif is the most recognizable 
pattern among Ca
2+
-independent proteins, however the IQ motif of some proteins can be also 
associated with Ca
2+
 bound CaM since they contain the same properties of being basic 
amphiphilic α-helices (Jurado et al., 1999). There are also a large number of Ca
2+
-independent 
proteins that do not have the IQ motif.  
1.1.3 Structural representation of CaM binding to target proteins 
In addition to the Ca
2+
 dependency of CaM‟s target protein, CaM can bind to its target 
protein in a variety of different conformations that demonstrate the diversity of CaM. The most 
common and well studied conformation of CaM is where the terminal lobes wrap around the 
target protein as in the myosin light chain kinase (MLCK) (Figure 1.3b) (Ikura et al., 1992). This 
classical binding conformation is common in both Ca
2+
-dependent and –independent groups 
because of the central linker region‟s ability to extend the accommodating distance of the 








a b c 
Figure 1.3. Calmodulin interactions with target proteins. 
These figures show a few different modes of CaM interacting with the CaM-binding region of 
target proteins in (a) and (b) and with the whole protein in (c). The CaM is shown as the blue-red 
structure representing the N to C terminal with the Ca
2+
 ions as yellow spheres and the target 
protein in gold. CaM can interact with its target protein by wrapping around it like in (a) myosin-
light chain kinase and (b) K
+
-channel. In a unique case, the target protein wraps around CaM, (c) 
Oedema factor from Bacillus anthraces. (More information in text). Structures were made from 
PDB 2O5G, 1G4Y and 1k93 for a, b and c respectively using Accelrys DS visualizer. 
 
More than one CaM can bind to its target protein such as in the case with potassium 
voltage gated channel. K
+
-channels exist as a heteromeric complex (Figure 1.3b) and two CaM 
are required where the main interaction is through the hydrophobic patches in the Ca
2+
-bound N-
terminal lobe (Schumacher et al., 2001). The N-terminal lobe interacts with hydrophobic amino 
acids on the α-helix of one monomer and on another α-helix of the second monomer whereas the 
C-terminal lobe helps to stabilize the dimer by enclosing a third α-helix (Schumacher et al., 
2001). The overall structure is an antiparallel dimer. A recent crystal structure of the exotoxin 
Oedema factor from anthrax adenylyl cyclase is one of the first to have a full structure of the 
protein bound to CaM (Figure 1.3c) (Drum et al., 2002). The study showed that CaM can interact 
with large areas of the target protein and initiate a large conformational change in the target 
protein that is required for protein activation (Drum et al., 2002). Aside from the three structures 





On a molecular level, CaM can interact in an anti-parallel where the N-terminal lobe of 
CaM binds towards C-terminal end of the target protein and the C-terminal lobe to the N-
terminal end or in a parallel manner where the terminals are orientated in the same direction 
(Yamniuk and Vogel, 2004). The determining factor for the orientation is which end of the target 
protein is more positively charged, since the outlet opening formed by CaM in its classical 
collapse wrapped around form is slightly more negative in the C-lobe than the N-lobe (Yamniuk 
and Vogel, 2004). In the majority of known peptides that bind to CaM, the N-terminus of the 
peptide is more positive and therefore binds to the C-terminal lobe of CaM in an antiparallel 
fashion. A few, such as the C-terminus of the peptide CaM kinase kinase, contain a larger 
positive charge and bind in a parallel fashion (Yamniuk and Vogel, 2004). 
An important protein that CaM binds to and activates is nitric oxide synthase. Nitric 
oxide synthase is a good model to study since it includes two isoforms that are Ca
2+
-dependent 
and one that is Ca
2+
-independent. The information provided on nitric oxide synthase in the next 
section was available at the start of the study in fall 2007. 
1.2 Nitric Oxide Synthase (NOS) 
Nitric oxide (•NO) is essential for controlling vital processes such as blood pressure 
through vascular dilatation, neuronal activity and as an immune response. This gaseous molecule 
is produced by the enzyme nitric oxide synthase (NOS) as a by-product of the conversion of L-
arginine into L-citrulline (Figure 1.4). The catalysis of L-arginine uses electrons in a form of a 
hydride from the NADPH and molecular oxygen. For each L-citrulline and •NO produced, 1.5 






Figure 1.4. A reaction scheme of NOS where L-arginine is converted into L-citrulline. 
The conversation of L-arginine to L-citrulline occurs as two mono-oxygenase reactions. The 
substrate L-arginine is converted first to the intermediate N-hydroxyarginine and then to the final 
product L-citrulline and nitric oxide using molecular oxygen and electrons from NADPH as a 
form of a hydride. Modified from Griffith and Stuehr (1995). 
 
1.2.1 Isoforms of NOS 
  There are three isoforms of mammalian NOS that are unique in cellular function. These 
three isoforms are endothelial (eNOS), neuronal (nNOS) and inducible (iNOS) nitric oxide 
synthase found in endothelial cells, neuron cells and macrophage (Daff et al., 2001). The •NO 
produced by eNOS controls vascular dilation and blood flow where in nNOS, it is responsible for 
neurotransmission and for iNOS, •NO is used in the immune system as a defense against 
pathogens. The size of each isoform varies, with nNOS, eNOS and iNOS having a molecular 
weight of 165, 133 and 130 kDa respectively (Zhang et al., 2001). All three isoforms catalyze the 
reaction in Figure 1.4 and require CaM for activation, but differ from each other with respect to 
how they respond to calcium concentrations and structural regulation. 
eNOS and nNOS are always expressed in the cytoplasm of the cell and are classified as 
constitutional NOS (cNOS). Since cNOS enzymes are always present, their enzymatic activity 
depends on increasing Ca
2+
 concentration in the cell and is active through Ca
2+
-bound CaM, 
(Loscalzo and Vita, 2000). Therefore the cNOS enzymes are Ca
2+
-dependent. iNOS, on the other 





immune system. As soon as iNOS is transcribed, it can bind to CaM in the absence or presence 
of Ca
2+
 and therefore is said to be Ca
2+
-independent (Griffith and Stuehr, 1995).   
 
1.2.2 Mechanism of electron transfer in NOS  
 The overall structures of the isoforms are very similar with an oxgygenase domain and a 
reductase domain separated by a CaM-binding region (Figure 1.5). The oxygenase domain 
contains binding sites for the cofactor tetrahydroxybiopterin, the catalytic heme and the active 
site. The reductase domain accommodates the cofactors, NADPH and the two flavins, FAD and 
FMN.  
 
Figure 1.5. General domain alignment of the three isoforms showing the location of the 
regulatory elements and cofactors. 
 Shown are the oxygenase and reductase domains and the locations of the cofactors in each 
domain, which are the same for each isoform. The coloured boxes in the reductase domain are 
NADPH, FAD, CD (connecting domain) and FMN domains.  The numbers represent the amino 
acid residue of each isoform. The autoinhibitory loop (AI) is in the FMN domain of the cNOS 
enzyme. The figure was modified from (Garcin et al., 2004) 
 The mechanism of electron transfer begins with NADPH passing two electrons in the 
form of a hydride ion to FAD to convert it to its reduced form, FADH2. FMN remains in a 
stable-semiquinone state (FMNH•) in its resting stage, and is converted to its hydroquinone 
form, FMNH2, when it receives an electron from FADH2 or FADH• (Craig et al., 2002).  The 





monomer where the electron acceptor is the heme. The first electron from FMNH2 goes to reduce 
O2 to produce a heme-dioxy and an electron from H4B reduces the heme-dioxy to produce the 
reactive heme-oxy used to oxidize the L-arginine and produce the intermediate N-hydroxy-L-
arginine (NOHA) (Figure 1.6) (Wei et al., 2008). A second electron from the FMNH2 goes 
through the heme network to reduce the H4B radical that was formed in the first step and the 
process with the heme-oxy is repeated to oxidize the NOHA to produce •NO and L-citrulline 
(Figure 1.6, step 6), (Wei et al., 2008, Stuehr et al., 2009).  
 
Figure 1.6. The reduction and oxidation of the catalytic ferric heme  
The catalytic reaction of NOS starts with L-arginine being reduced by a reactive heme-oxy that 
is produced from steps 1 to 5 to make the intermediate N-hydroxyarginine (NOHA).  The first 
two electrons are from FMNH2 and H4B. A freshly reduced FMNH2 reduces H4B
•+ 
back to H4B 
allowing the reduction process of the NOHA (steps 7-10) to continue in the same manner as L-
arginine but this time producing L-citrulline and •NO (steps 10-11). Modified from Wei (2008) 






The majority of electron transfer occurs in the reductase domain using the cofactors 
NADPH, FAD and FMN (Figure 1.7). The electron flow through the reductase domain can be 
measured using enzymatic kinetic assays, such as the cytochrome c assay (Feelisch and Stamler, 
1996). The cytochrome c assay measures the electron donating ability of the FMN, which is the 
cofactor responsible for the transfer of electrons to the heme in the oxygenase domain. Therefore 
results from cytochrome c assay are comparable to the FMN passing an electron to the heme.  
 
Figure 1.7. Schematic of electron flow in NOS with points of CaM control and cytochrome 
c assay. 
The electron transfer from the reductase cofactors, NADPH, FAD and FMN to the heme can be 
monitored through the cytochrome c assay. The cytochrome c is able to accept electrons only 
from the FMN. In measuring the amount of electron transfer the cytochrome c accepts, a 
measure of the FMN transfer rate can be determined which would be equivalent to the transfer to 
the heme. CaM controls the flow of electrons between the flavins and in the transfer of electrons 
to the heme from the FMN. Modified from Spratt et al. (2007a). 
 The binding of CaM to the NOS enzymes increased the rate of cytochrome c reduction 
tenfold in the presence of CaM (Sheta et al., 1994). The binding of CaM also increased the 
electron flow through the reductase domain (Abu-Soud et al., 1994). Therefore CaM is an 
extremely important co-protein in the catalytic activity of NOS by allowing electron transfer 






1.2.3 CaM-binding region of NOS 
CaM is essential for the activation of the NOS isoforms.  The binding affinity of CaM for 
each of the isoforms differs, with the highest binding affinity being iNOS, nNOS then eNOS 
(Ghosh and Salerno, 2003). The peptide sequence codings for the CaM-binding site of the three 
isoforms (Figure 1.8) follow the Ca
2+
-dependent binding motif since they are composed of 
hydrophobic and basic amino acids arranged in a 1-5-8-14 pattern (Aoyagi et al., 2003).  
 
Figure 1.8. Sequence alignment of the CaM-binding region of human NOS isoforms 
Highlighted in red are the hydrophobic/non-polar amino acids and in bold are conserved amino 
acid in the isoforms. The nNOS and eNOS have more conserved amino acid than the iNOS but 
the iNOS contain more hydrophobic residues. The numbers on either side of the sequences 
indicate the amino acid residues. The numbers at the top with arrows indicate the amino acid 
used for characterizing the binding motif, 1-5-8-14. 
The CaM binding region of the NOS isoforms was narrowed down by examining the 
NOS sequence for large hydrophobic patches that resemble the sequence of the Myosin light 
chain kinase (Venema et al., 1996). Using electrophoretic mobility shifts, they were able to 
determine the minimum amino acid sequence required to form a complex with CaM (Venema et 
al., 1996, Zhang et al., 1995). Mutation of key hydrophobic residues, Phe, Val and Leu to alanine 
resulted in no binding complex with CaM, therefore these residues play an important role in 
NOS binding to CaM (Venema et al., 1996). The sequence found that was required for CaM 
binding was residues 285-747, 492-510 and 501-531 for nNOS, eNOS and iNOS, respectively 
(Aoyagi et al., 2003, Matsubara et al., 1997, Venema et al., 1995, Venema et al., 1996, Zhang et 





hydrophobic residues, Phe/Leu and Leu, are in an alpha helical conformation whereas the extra 
amino acids are in an extended conformation (Aoyagi et al., 2003, Ikura et al., 1992). 
 The cNOS peptide sequences are 54% identical whereas iNOS differs by 42 and 30% 
from nNOS and eNOS peptide respectively. Despite iNOS being classified as Ca
2+
-independent, 
it does not follow the IQ motif but is more similar to the Ca
2+
-dependent motif. However, the 
differences in iNOS from the cNOS enzymes are the presence of more hydrophobic amino acids 
and a much larger patch of them. The arrangement of the iNOS peptide in a α-helix conformation 
forms larger surface areas for hydrophobic interaction with CaM and accounts for the tight 
binding to CaM (Aoyagi et al., 2003). .  
At the start of this study, available crystal structures were those of eNOS peptide (Aoyagi 
et al., 2003) and nNOS peptide (Valentine et al., 2006) bound to CaM (Figure 1.9) and both have 
CaM bound in the classic conformation. Both peptides form an α-helix and the phenylalanine in 
position 1 of the Ca
2+
-dependent binding motif binds deep in the hydrophobic pocket formed by 
the methionine in the C-terminal lobe of CaM (Figure 1.9c&d). The other anchoring residue at 
position 14, a leucine, binds in the hydrophobic pocket of the N-terminal domain. Close 
inspection of the crystal structure shows that the nNOS peptide binds closer to the C-terminal 


















Figure 1.9. Comparison of the crystal structures of eNOS and nNOS 
The peptides from the CaM binding region of eNOS (a) and (c) and nNOS (b) and (d) are shown 
in gold with the N-terminus end pointing out of page. (c) and (d) The amino acid residues 
involved in the 1-5-8-14 (Phe-Ala-Val-Leu) are shown as ball and stick figure. (a) and (b) CaM 
is shown as the blue and red structure, where blue represents the N-terminal domain and red 
represent the C-terminal domain in structure. In the blue line ribbon representation of CaM (c) 
and (d), the methionine residues of CaM are shown as blue ball and stick structure. The CaM 
orientation remains identical to that of (a) and (b) respectively. Structures were made from PDB 
1N1W and 2O60 for eNOS and nNOS respectively using Accelrys DS visualize. 
From the crystal structures, CaM binds to the cNOS enzyme in an anti-parallel manner 
which was verified by FRET studies that studied the orientation of the CaM binding lobe with 
respect to the terminus of the peptide (Spratt et al., 2007b). From the same FRET study, Spratt et 
al. (2007b) showed that the orientation for CaM bound to the iNOS peptide is also in an 
antiparallel orientation. The secondary structure of iNOS when bound to CaM is also known to 
be in an α-helix structure using circular dichroism (Yuan et al., 1998).  
NOS chimeras using the iNOS oxygenase or CaM-binding region or reductase domain to 
replace those of nNOS resulted in chimeras that were more sensitive to Ca
2+





none obtained the full Ca
2+
-independence of iNOS (Lee and Stull, 1998). This study was able to 
show that the CaM-binding site of iNOS as well as other regions in the reductase and oxygenase 
domains were also responsible for iNOS Ca
2+
-independence (Lee and Stull, 1998).  
1.2.4 Regulatory Elements 
The domain alignment of the isoforms (Figure 1.5) indicates a unique regulatory element 
in the cNOS enzymes, the autoinhibitory loop, and a common element for all three isoforms, the 
C-terminal tail (Garcin et al., 2004). These regulatory elements in conjunction with CaM are able 
to regulate the enzyme activity of NOS. 
The autoinhibitory (AI) loop is found only in the cNOS enzymes and contributes to their 
Ca
2+
-dependent properties (Garcin et al., 2004, Daff et al., 1999).  When the AI loop was 
removed in the cNOS, cytochrome c reduction for both eNOS and nNOS increased 
approximately twofold in the absence of Ca
2+
 when compared to that of the wild-type 
(Montgomery et al., 2000, Knudsen et al., 2003).  Therefore the AI loop is responsible for some 
of the cNOS enzyme‟s Ca
2+
-dependence. For eNOS in the presence of CaM, the •NO production 
increased by a factor of two when the loop was removed, indicating more electron transfer to the 
oxygenase (Knudsen et al., 2003). The insertion of the AI loop of eNOS into iNOS reductase 
domain caused the enzymatic activity to decrease to a third of the wild-type (Knudsen et al., 
2003).  In the crystal structure of the reductase domain, the loop lies within the FMN binding site 
and is thought to directly interact with CaM (Salerno et al., 1997, Garcin et al., 2004). It has been 
proposed that the AI loop locks FMN in its electron accepting position and when CaM binds, it is 
able to displace the AI loop and free the FMN domain to transfer electrons (Garcin et al., 2004). 
Clearly, the AI loop plays an important role in Ca
2+
 dependency of the cNOS enzymes restricting 
activity until there is a high enough concentration of Ca
2+





The C-terminal tail is present in all three isoforms but varies in length with nNOS having 
the longest tail and iNOS the shortest.  Studies by Roman et al. (2000) and Garcin et al. (2004) 
showed that when the C-terminus was truncated in the cNOS enzyme, the electron flow in the 
reductase domain increased significantly based on the measurement of the FMN reducing 
cytochrome C (Figure 1.7) and did so independently of CaM.  nNOS and eNOS in the absence of 
CaM were reducing cytochrome c twenty-one and seven times more respectively than that of the 
wild-type enzyme with CaM bound (Roman et al., 2000). These results show that the C-terminal 
tail is responsible for restricting electron transfer in the reductase domain, since without the C-
terminal tail, electron flow through the reductase domain increases. The C-terminal tail of cNOS 
is also required for maximum production of •NO since the •NO production of truncated cNOS in 
the presence of CaM compared to wild-type cNOS was reduced by 50% (Roman et al., 2000). Of 
note, the cNOS enzymes were able to produce low levels of •NO even in the absence of CaM. 
Therefore the C-terminal tail is proposed to play a role in the electron transfer between the two 
domains by locking the FMN cofactor in the electron accepting position (Craig et al., 2002). The 
binding of CaM is able to overcome the effects of the C-terminal tail. In iNOS, where CaM is 
always bound, the removal of the C-terminal tail resulted in an increase in cytochrome C 
reduction, an increase in •NO production and an increase in the flavins oxidization by molecular 
oxygen (Roman et al., 2000). Therefore the shorter C-terminal tail in iNOS is responsible for 
restricting electron flow in the reductase and for protecting the flavins from oxidation (Roman et 
al., 2000, Garcin et al., 2004).  
In summary, the AI loop and the C-terminal, in addition to CaM, control the flow of 










1.2.5 Structure of nitric oxide synthase enzymes 
There are no full intact structures of any of the isoforms available due to proteolysis in 
the CaM-binding region and high mobility region, which makes crystallization difficult. 
Structural determination using nuclear magnetic resonance (NMR) is restricted since the NOS 
enzymes are so large. At the start of this study, available structures included the oxygenase 
domain of all three isoforms (Fedorov et al., 2003, Li et al., 2001, Matter et al., 2005, Fischmann 
et al., 1999, Rosenfeld et al., 2002), the reductase domain of nNOS (Garcin et al., 2004) and 
CaM bound to the CaM-binding region of eNOS (Aoyagi et al., 2003) and nNOS (Valentine et 


























Figure 1.10. Solved crystal structures of nNOS oxygenase and reductase domains and the 
CaM-binding regions of nNOS and eNOS in complex with CaM 
The crystal structure of (a) iNOS, (b) eNOS and (c) nNOS oxygenase domain dimer containing 
co-factors: heme and H4B, and substrate L-arginine represented in yellow, green and pink ball 
and stick figures respectively. The cyan ball between the dimers is the Zn
2+
 ion. In the (d) nNOS 
reductase domain the cofactors: NADPH, FAD and FMN are represented in teal, magenta and 
orange, respectively. The Ca
2+
 ions in the CaM bound to the peptide from CaM-binding region 
of (e) nNOS and (f) eNOS are shown as yellow spheres. All NOS structures go from blue to red 
showing the N-C terminus. Structures 3E65, 1FOP, 1ZVL, 1TLL, 2O60 and 1NIW for (a), (b), 





The oxygenase domains (Figure 1.10a-c) of all three isoforms have very similar fold, and 
all three contain the heme and the H4B situated near the dimer interface, which also contains a 
binding site for a zinc metal (Fischmann et al., 1999, Rosenfeld et al., 2002).  The structure of 
the reductase domain of nNOS was the first to confirm that the reductase domain existed as a 
dimer, which is stabilized by salt bridges and hydrogen bonding in the interface (Garcin et al., 
2004). The reductase domain as a dimer was first shown by Venema et al. (1997) using low-
temperature SDS-PAGE gel to show the migration of dimers or monomers of the NOS isoforms. 
eNOS and nNOS both formed dimers in both oxygenase and reductase domains whereas iNOS 
formed a dimer in the oxygenase domain only. Therefore the iNOS reductase domain could be 
rearranged differently from the structure shown. As mentioned in section 1.2.3, cNOS are α-
helical and bind in an antiparallel fashion such that the C-terminus and N-terminus of CaM 
interact closely with the N-terminus and C-terminus of the peptide respectively.  
1.2.6 FMN swing model 
The reductase domain of nNOS solved by (Garcin et al., 2004) gives significant insight 
into the orientation of the cofactors and regulatory elements. Based on the reductase crystal 
structure (Figure 1.11), the cofactors NADPH, FAD and FMN are within close proximity of each 
other for electron transfer. The FMN cofactor is tucked within the interface formed by the FAD 
and NADPH domain and is within ~4 Å from its electron donor, FAD (Ghosh and Salerno, 
2003).  In this position, the FMN cannot pass an electron to the heme in the oxygenase domain, 






Figure 1.11.  A closer look into the subdomains of the reductase domain using rat neuronal 
nitric oxide as the model. 
The cofactors: NADPH, FAD and FMN are represented in teal, magenta and orange, respectively 
in each of their domains. Portions of the crystal structure are missing such as the autoinhibitory 
loop and the hinge region, most likely due to the region being highly mobile. Structure made 
from PBD 1TLL (Garcin et al., 2004) using Accelrys DS visualizer. 
Based on the structures available it was proposed that subunit realignment and 
conformational changes had to occur to allow for the FMN domain to shuttle electrons from the 
FAD to the heme (Garcin et al., 2004, Ghosh and Salerno, 2003). Since CaM initiates the 
electron transfer between the two domains, CaM plays an important role in this dynamic process. 
The hinge region (Figure 1.11) at the end of the CD and start of the FMN domain is 
flexible due to some portion of it being unstructured and acts as a pivot point allowing the FMN 
domain to swing back and forth between the FAD and heme (Garcin et al., 2004, Ghosh and 
Salerno, 2003). The surface of the oxgygenase domain near the heme interface is positively 
charged while the FMN domain is negatively charge allowing for a good docking area for the 
FMN domain (Garcin et al., 2004). Therefore the proposed model is similar to that in Figure 





oxygenase domain. The distance that the FMN cofactor is proposed to move is 55 Å to bring the 
FMN within 15 Å of the heme (Garcin et al., 2004). 
 
          
        a                                                              b 
Figure 1.12. Cartoon representation of a NOS dimer showing the flow of electrons. 
The ovals at the top of the figure represent the oxygenase domains and the rectangles are part of 
the reductase domain. The long rectangle joining the oxygenase and reductase domains is the 
CaM-binding region. CaM is shown as the red object. (a) The arrows show the flow of electrons 
starting from NADPH to the FAD to the FMN domain in the reductase domain. (b) When CaM 
binds, the FMN domain can swing up towards the heme in the oxygenase domain and pass an 
electron. Figure was modified from (Daff et al., 2001, Garcin et al., 2004). 
 Exactly how CaM is able to initiate this process is still not fully understood. The binding 
of CaM is known to displace regulatory elements in the cNOS enzymes and C-terminal tail but 
structurally, it remains to be seen. Contrary to the cNOS enzymes, iNOS does not have the AI 
loop and is Ca
2+
-independent and may behave differently than the cNOS. Common to all three 






1.3 Structure determination using nuclear magnetic resonance (NMR) 
There are two main methods to determine 3-D protein structures; x-ray crystallography 
and nuclear magnetic resonance spectroscopy. Both methods have their advantages and 
disadvantages.  X-ray diffraction of crystallized protein is useful for large proteins and can give 
high resolution structures; however, it requires the production of suitable single crystals. 
Crystallization of protein can prove to be difficult, especially with highly dynamic proteins or 
those prone to proteolysis, and misinterpretation can occur due to artifacts from crystallizing 
conditions and contacts between different molecules in the crystal.  NMR is better suited for 
observing proteins that are highly dynamic. A drawback of NMR is that the large protein can 
complicate assignments and cause crowding in the spectra. Proteins under 30000 Da are the best 
candidates. As in crystallization, proteins for NMR need to be soluble at high concentrations 
(~0.1 – 1.0 mM). In addition, proteins for NMR structure determination require incorporation of 




C. (Brändén and Tooze, 1999). 
 NMR experiments detect the unique resonance frequencies of NMR active nuclei when 
they are exposed to rf-radiation inside a strong external magnetic field.  Specific experiments can 
give rise to a set of signals that can be analyzed with respect to molecular structure, dynamics 
and protein interactions (Roberts, 1993a). Still a relatively new structural method, it has grown 
drastically due to the development of multi-dimensional NMR, advances in pulse sequences and 
modern equipment.  For large proteins, two or higher dimensional NMR is required since one 
dimensional spectra yield poor peak dispersion and large overlap of signals. Two or higher 
dimensional experiments are based on correlation of two or more nuclei resonance frequencies of 
different elements through bond-bond or space and allow for the assignment of the correlation 





easier with 3D and 4D NMR since they expand a 2D spectrum into another dimension and thus 
overlapping areas are separated into layers and the amount of crowded peak areas is reduced. 
Figure 1.13 shows the separation of a 2D NMR spectrum in the z direction, which correlates to 
another resonance frequency to resolve overlapping peaks and to allow for clear assignments.  
 
 
Figure 1.13. Overlapping peaks of 2D NMR spectrum resolved in the 3D NMR spectra. 
In the 2D spectrum, the peaks represent correlation peaks between two types of nuclei: X and Y. 
There are areas where overlap occurs, which are resolved in the 3D spectra.  In the 3D spectrum 
each of the X-Y correlation peaks is correlated to another nucleus, Z. 




N-heteronuclear single quantum 
correlation (HSQC) experiment. This experiment correlates nitrogens in the protein with their 
directly bound protons. This includes the side chain amides and those in the back bone of the 




N-HSQC is the first spectrum to be run since 
the peaks that appear in the spectrum represent a “finger print” of the protein.  Assignments of 
the peaks in HSQC spectra cannot be accomplished without other 3D heteronuclear experiments.  




N peaks to the alpha or side chain carbons.  A 






Figure 1.14. The path of magnetization in NMR 3D heteronuclear experiments  
Three heteronuclear NMR experiments that help assign the backbone of the protein by 
expanding the 
15
N-HSQC in the carbons direction.  The stars indicate the nuclei that contribute to 
the peaks in the spectrum. The HNCA (red) allows for the assignment of the amide to the alpha-
carbon of the same residue and to the previous alpha-carbon. The HNcoCA (blue) helps confirm 
which peak of the HNCA corresponds to the previous alpha-carbon to rule out any ambiguities. 
The CBCAcoNH (yellow) further confirms the previous alpha-carbon as well as confirming the 
correct amino acid residue by using some unique alpha and beta carbon patterns produced by 
different amino acids. (For NMR experiments see Appendix B) 
 Other experiments that are useful are total correlation spectroscopy (TOCSY), which is a 
2D experiment that helps proton assignments in the side chain and correlates it to the alpha 
carbon and nuclear Overhauser effect spectroscopy (NOEs). The NOES gives interaction 
between proteins through space, as long as they are within 5 Å, allowing for the determination of 
secondary and tertiary structures.  These experiments together allow for a family of structures 
that best fit the data and can demonstrate dynamics by the range of structures obtained. 
1.4 Research Objectives  
At the beginning of this investigation, there has been no full intact structure of any of the 
NOS isoforms. Available were the oxygenase domains, reductase domain of nNOS and the CaM 
binding region of the cNOS enzyme bound to CaM. All the information concerning the role of 





cNOS enzymes. These studies indicated that the reductase domain had to undergo a significant 
structural rearrangement to allow for electron transfer to the oxygenase domain. iNOS is 
different from the other isoforms since it does not contain the AI loop, its proposed that its 
reductase domain does not form a dimer like the crystal structure of nNOS and is Ca
2+
-
independent (Venema et al., 1997). Very little structural information of iNOS is known since, at 
the start of this study, no three-dimensional structure of its reductase domain had been reported. 
Therefore the overall research objective was to investigate the dynamic properties of the FMN 
domain of iNOS and its association with CaM using nuclear magnetic resonance (NMR).  
Since the FMN domain is about 30 kDa, the first phase of this investigation was to 
determine the three dimensional structure of CaM bound to the 24 amino acid iNOS CaM-
binding region. This required the optimization of methods for expressing and purifying the 





Chapter 2 NMR investigation of calmodulin bound to the iNOS CaM binding 
region  
2.1 Introduction 
Three dimensional protein structure studies provide important insight into the function of 
proteins.  These studies can confirm or contradict results from previous investigations, provide 
new insight into function and regulation and are useful for drug design.  Since the dynamics of 
the FMN domain will eventually be investigated, NMR structural determination is the more 
logical and applicable method to use. In this investigation, we are trying to determine the 
structure of CaM bound to the iNOS CaM-binding region as a first step in the investigation of 
the structural dynamics of the FMN-CaM binding domain. 
 It is known that iNOS binds to CaM with the highest affinity out of the three isoforms. 
iNOS also differs from the other isoforms by being Ca
2+
-independent and is always bound to 
CaM in vivo. At the initiation of this project, the structures for the other isoforms bound to CaM 
have been reported, but there has been no structure reported of the iNOS enzyme reductase 
domain.  
 To obtain the structure of the iNOS CaM-binding region bound to CaM using NMR 
requires two main processes. The first is to assign the NMR spectra of isotopically labeled wild 
type CaM bound to unlabeled peptide of the iNOS CaM-binding region.  The second is to assign 
the spectra of the isotopically labeled iNOS CaM-binding region peptide bound to unlabeled 
CaM.  Producing isotopically labeled proteins for NMR can be troublesome since they are 
expressed in bacteria grown in minimal media, and the final concentration required to conduct 
successful NMR experiments is 1.0 mM in a volume of 500 µL (Montelione et al., 2000).  Some 





with CaM. However, others like the iNOS CaM-binding region are more problematic.  
Compared to the CaM-binding region of the other two NOS isoforms, the iNOS CaM-binding 
region has more hydrophobic amino acids and larger hydrophobic patches (Figure 1.8), which 
contribute to the peptide being insoluble (Matsubara et al., 1997, Spratt et al., 2006). Previous 
expression studies of the twenty-four amino acid long iNOS peptide in minimal media by Spratt 
(2008) using the poly-histidine tag vector, and the preliminary use of New England Biolab 
IMPACT-Twin intein self-cleavage expression system, have shown that the majority of the 
protein was insoluble. The protein in the inclusion bodies can be an advantage since a paper by 
Guo et. al. (2004) showed a successful extraction of their IMPAC-Twin expressed protein from 
the inclusion body using a step-wise dialysis method. For production of more soluble protein, 
lower induction temperatures accompanied by a prolonged period have been shown to increase 
solubility (Vaillancourt, 2003). 
 In this section the method for the expression and purification of a peptide from iNOS 
CaM-binding region (iNOS peptide) in minimal media was optimized to produce the required 
amount for NMR experiments. Included in the method was the attempt to refold proteins in the 
inclusion. The expression and purification process of isotopically labeled CaM had already been 
optimized by Spratt (2008).  HSQC and 3D NMR experiments were run for the labeled iNOS 
peptide in complex with unlabelled wild-type holo-CaM to obtain spectra that are currently being 
assigned. The NMR spectra of isotopically labeled holo-CaM titrated with synthetically made 
iNOS peptide were completed prior to the start of this study and are also currently being 
assigned. So far, the EF hand regions have their backbone assigned where the central linker 
region of CaM bound to the iNOS CaM-binding region is still undetermined. The chemical shift 





shift than the C-terminal. For the assignment of the iNOS peptide, NOEs shows some α-helical 
properties. 
2.2 Methods 
2.2.1 Expression vectors 
2.2.1.1 pTYB12 vector for the expression of iNOS CaM-binding region 
Vectors for the production of the iNOS CaM-binding region were made by Spratt (2008). Spratt 
(2008) initially expressed the iNOS peptide using a poly histidine tag but that resulted in low 
yields due to protein insolubility. Expression trials in 2 L of minimal media for the poly-histidine 
tag fusion protein produced only 500 µL of 0.068 mM of protein. He then used the intein 
mediated purification with an affinity chitin-binding tag (IMPACT) system sold by New England 
Biolabs that had more promise in producing soluble proteins and a simpler purification process.  
This system consists of a chitin-binding domain (CBD) fused to the protein of interest via an 
intein linker (Figure 2.1).   
 
Figure 2.1. Representation of IMPACT fusion protein. 
The IMPACT system adds a fusion tag that consists of the chitin-binding domain (cyan) and an 
intein linker region (green). The fusion tag is 55 kDa and attaches to the target protein via the 
intein linker.  
 The iNOS CaM-binding region was cloned into the vector pTYB12 that contains the 





(Figure 2.2).  The restriction enzyme sites are located at the 3‟ end of the CBD therefore the 
iNOS peptide is attached to the fusion tag by its N-terminal.  The cleavage process adds three 
extra amino acids to the N-terminus of the iNOS CaM-binding region peptide as shown by the 
underlined amino acids to produce a sequence of:  
AGHMR PKRRE IPLKV LVKAV LFACM LMRK. 
Shown in red are the amino acids of the iNOS CaM-binding region. A few additional amino 
acids, shown in blue, were from the NdeI cut site so the peptide that is produced is 29 amino 
acids long with a molecular weight of 3.4 kDa. Since CaM interacts with target proteins between 
the anchoring amino acid in 1-5-8-14 motif, extra amino acid would not interfere with CaM 
binding (Aoyagi et al., 2003). 
 
Figure 2.2. pTYB12 vector map showing restriction enzyme site for cloning in iNOS CaM-
binding region. 
The IMPACT pTBY12 vector contains an ampicillin resistance gene and an CBD-intein that was 
fused to the iNOS-CaM binding region by insertion at the NdeI and PstI sites.  The location of 
the restriction enzyme sites allows for ligation of the fusion tag to the N-terminal of the iNOS 
peptide. (A) The pTBY12 in its circular form, showing the location of the important genes 
labeled using the red arrows. (B) A linear representation of the vector. Figure was made from 





The recombinant protein is expressed using the recommended E. coli ER2566 cells (New 
England BioLabs, 2006). This strain contains the T7 RNA polymerase that is under the control 
of a lacI repressor which is released after the addition of IPTG to allow for the production of the 
protein.  It also lacks lon and ompT proteases, which can degrade foreign or short proteins. 
2.2.1.2 pET9d for the expression of Calmodulin 
The vector pET9d (NOVAGEN) used to express the rat calmodulin was made by 
Newman (2003) by cloning in the CaM sequence using restriction enzyme sites, NcoI and 
BaMHI. The vector contains a kanamycin resistance gene that allows for selection of all cells 
containing the vector.  There is no fusion tag associated with this vector since CaM can be easily 
purified using a single step purification process by using hydrophobic affinity column (see 
section 2.2.6.2).  Competent cells BL21DE3 were used to express this protein. 
2.2.2 Expression of protein in minimal media containing labeled isotope  
2.2.2.1 Expression of the iNOS CaM-binding region using IMPACT-Twin system  
 Fresh ER2566 competent cells were prepared using a single colony to 1L of LB medium 
at 37
o
C until an OD of 0.5 – 0.7 was reached. The pellet was harvested using sterile centrifuge 
bottles and spun down at 6000 rpm for 7 minutes at 4
o
C. The cell pellet was washed 
(resuspended and pelleted) twice with sterilized water, and once with 10% glycerol as the 
resuspension solution, respectively. The pellet was then resuspended in minimal volume, 1-2 
mL, of 10% glycerol. The iNOS peptide vector was transformed in 40 µL of the fresh ER2566 
competent cell by electroporation and plated on a selective agar plate containing 100 µg/mL 
ampicillin. An isolated colony was grown in 3 mL LB media that was used to inoculate the 





Table 2.1 Minimal Media Ingredients 
Components
a
 50 mL Starter 
Culture in  
250 mL Flask  
1 Liter Growth 
Culture in 4 L 
Flask 
Final Concentration 
10X M9 Salts Stock soln:  
114 g Na2HPO4·7H2O  
30.0 g KH2PO4  
5.0 g NaCl 
In 1 liter 
5 mL 100 mL 1X 
20% N
b
 -NH4Cl   250 µL 5 mL 0.1 % or 0.001 g/mL 
40% C
b
-Glucose 250 µL 5 mL 0.2 % or 0.002 g/mL 
2 M MgSO4 50 µL 1 mL 2 mM 
0.05% Thiamine 50 µL 1 mL 0.00005 % or 5 mg/mL 
100 mg/mL Ampicillin 50 µL 1 mL 100 µg/mL 
0.2 M CaCl2 25 µL 500 µL 100 µg/mL 






For sterilization of the components of the media, M9 solutions were sterilized at 121
o
C using an 
autoclave whereas all other solutions were filtered through a 0.2 µm pore sized filter. Method 




N- NH4Cl and 
12
C-Glucose was used in the minimal media sample with the exception of 1 
L growth culture that were being prepared for NMR experiments where 
15
N- NH4Cl and 
13
C-
Glucose were used 
c
Starter culture from 3 mL LB media culture 
d
Starter culture from 50 mL minimal media culture 
 The expression trials of the desired protein were prepared in minimal media. Minimal 
media contains M9 salts (disodium hydrogen phosphate heptahydrate (Na2HPO4·7H2O), 
monopotassium phosphate (KH2PO4), sodium chloride (NaCl)), ammonium chloride (NH4Cl), 
glucose, magnesium sulfate (MgSO4), thiamine and antibiotic in concentrations according to 
Table 2.1 (Roberts, 1993a).  500 µL of the LB starter culture was used to inoculate the minimal 
media starter culture, which contained no isotopes, and which was allowed to grow in a shaker 
set to 160 rpm at 37
o
C until an OD600 of about 0.6 was reached (about 6 hours). The 1 L minimal 
media was prepared in 4 L flasks and inoculated with 5 mL of the minimal media starter culture 





 a)  Inclusion body production 
For the production of proteins in the inclusion bodies 2 L of minimal media was used to express 
the recombinant protein. The cells in the minimal media samples were induced at an OD600 of 0.9 
(about 11 hours) with 1 mM IPTG. Induction period was found to be optimal for 6 hours at 37
o
C 
at which point the cell pellet was collected, frozen using dry ice and stored at -80
o
C. 
 b) Soluble protein production 
For the production of soluble protein 4 L of minimal media growth was required. Protein 
production was induced at 15
o
C with 1 mM of IPTG when the OD600 reached 0.9 – 1.0 (about 11 
hours). The induction period was extended to 20 hours at which point the cells were either 




2.2.2.2 Expression of recombinant CaM  
 Calmodulin was expressed and purified as previously reported in Spratt (2008) with the 
expression in minimal media and was uniformly labeled with 
15




C isotopes.  The purification was performed by phenyl-sepharose affinity chromatography 
according to Gopalakrishna and Anderson (1981).  
2.2.3 Purification of recombinant proteins 
2.2.3.1 iNOS CaM binding domain 
a) Protein extraction from inclusion bodies 
The pellet obtained from a 2 L minimal media growth that produced insoluble protein in 
section 2.2.2.1.1 was refolded according to Guo et al. (2004). The protocol used for the iNOS 





pellet was homogenized in intein lysis buffer (20 mM Tris pH 7.5, 500 mM NaCl, 1 mM CaCl2 
and 0.01% Triton X-100) in a 1:10 (1 gram: 10 mL of buffer) ratio and lysed by passing solution 
through an emulsifier. After centrifugation the insoluble fraction in the pellet portion was washed 
twice with the buffer A (50 mM Tris pH 7.0, 500 mM NaCl) which contained 0.1% Triton X-100 
and 1 M urea. This step ensures that any small cell debris such as cell wall and small non-
essential proteins were removed. The remaining pellet was resuspended in an extraction buffer 
(50 mM Tris pH 7.0, 500 mM NaCl, and 8 M urea) by shaking at room temperature for 4 hours. 
Any remaining precipitate was removed by centrifugation and the supernatant was transferred to 
dialysis tubing with the addition of wild-type CaM. The dialysis tubing was placed in a large 
mixing chamber that contained 1.5 liters of the base buffer with 7 M urea at 4
o
C. The 
concentration of urea was reduced by 1 M every 18-20 hours by dripping in buffer A until a 
concentration of 1 M was reached.  Before each addition of buffer A, the solution in the dialysis 
bag was spun down to remove any precipitate. After dialysis in buffer A with 1 M urea, the 
sample was dialyzed in the 1.5 L of refolding buffer (20 mM Tris-HCl pH 7.0, 500 mM NaCl, 
0.2 mM GSH, 0.02 mM GSSG and 0.5 M L-Arg) for 18 hours.  The refolded solution was then 
purified as usual via chitin bead column (section 2.2.3.1 b)  
 
b) Purification of soluble IMPACT recombinant protein  
 The pellet obtained from 4 L of minimal media culture growth was resuspended in the 
intein lysis buffer (20 mM Tris pH 7.5, 500 mM NaCl, 1 mM CaCl2 and 0.01% Triton X-100) in 
a 1:10 (1 gram: 10 mL of buffer) ratio with the addition of unlabelled CaM for a final 
concentration of 10 µM. This suspension was passed through an Avestin EmulsiFlex-C5 





10 mL bed volume of chitin beads.  Prior to the addition of the supernatant, the chitin bead 
column was equilibrated with ten times column volume of wash buffer (20 mM Tris pH 7.5, 500 
mM NaCl, 1 mM CaCl2). Contaminating proteins were removed by washing the column after the 
addition of supernatant with another ten times column volume of wash buffer at a rate of 2.0 
mL/min.  For elution of the protein, the column was incubated at room temperature in cleavage 
buffer (20 mM Tris pH 8.5, 500 mM NaCl, 1 mM CaCl2, and 50 mM DTT) for 48 hours. Under 
these reducing conditions the Asn454 located at the C-terminus of the intein tag is induced to 
form a succinimide and break the bond between the iNOS CaM-binding region and the fusion 
tag (New England BioLabs, 2006). Elutions were collected in 2 mL fractions by passing a pH 8.5 
wash buffer through the column. 3 µL samples from each fraction were used to run on a Tris-
tricine gel (section 2.2.4) to determine which fractions contained the iNOS CaM-binding region.  
The appropriate fractions were pooled together, concentrated down to 1 mL using the Viva spin 
column with the 3 kDa cut off and then run through a Superdex 75 10/300, 500 µL at a time. The 
wash buffer used for the chitin bead was also used in the gel filtration process. The fractions 
containing the desired protein were concentrated down and were quantified using the Lowry 
method with CaM as the standard. Protein purity was confirmed by a final SDS-PAGE gel and 




2.2.3.2 Isotope labeled CaM 
 The purification of CaM utilizes the hydrophobic properties of CaM when it binds to 
Ca
2+
 in a one step chromatographic process using the phenyl-sepharose affinity column. The 
lysis process is similar to that of iNOS CaM binding domain but the lysis buffer used was 





purification process was carried out according to the methods in (Gopalakrishna and Anderson, 
1981), with buffer 1 being 50 mM Tris-HCl pH 7.5 and 1 mM CaCl2 and the elution buffer 
containing EDTA instead of EGTA.  The eluted fractions were checked for the presence of CaM 
by scanning the solution from 250 to 300 nm looking for the signature peak pattern of CaM due 
to its lack of tryptophan and large ratio of phenylalanine to tyrosine (Klee et al., 1980).  
 
Figure 2.3. Spectroscopic analysis of CaM. 
Characteristic spectrum of purified CaM showing peaks at 277, 269, 265, 259 and 253 nm.  
  The fractions that contained the CaM peaks were pooled together and dialyzed in buffer 
overnight using 6-8 kDa cut off dialysis tubing.  A Lowry was performed to determine the 
concentration of CaM produced. The protein solution was separated into 500 µL aliquots, frozen 
on dry ice and stored at -80
o
C.   
2.2.4 Tris-Tricine SDS-PAGE Visualization of iNOS CaM-binding region 
The protein produced from pTBY12 vector (CBD-intein-iNOS peptide) was about 60 
kDa but after cleavage from the fusion tag, the peptide portion was only 3.7 kDa, which was too 
small to monitor using SDS-PAGE analysis. However, during the purification process the CaM 





the presence of the iNOS peptide. Therefore the presence of CaM would also indicate the 
presence of the iNOS peptide. Although CaM is 17 kDa and can be seen on a traditional SDS-
PAGE gel, the 16.5% acrylamide Tris-tricine gel was used because it allows for the detection of 
small proteins as low as 4kDa. The method used was a modified version of Schagger and von 
Jagow (1987). 
A 3x separating gel buffer was made with the final concentration of 3 M Tris-HCl pH 
8.43, 0.3% SDS, 3% glycerol. For 12 mL the separating gel that is enough to make two 15x15 
cm gels, 4 mL of the 3x separating buffer, 6.6 mL of 30% acrylamide and 1.4 mL of water was 
used.  This ratio produces a final concentration of 33.3% of 3x buffer and 16.5% of acrylamide.  
For stacking gel, the 3x stacking buffer consisted of 3 M Tris-HCl pH 8.43 and 0.3 % 
SDS. For two gels, a 5 mL preparation used 1.67 mL of 3 x stacking buffer, 0.66 mL of 30% 
acrylamide and 2.67 mL of water to make a final concentration of 33.33% of stacking buffer and 
4 % acrylamide. A little (10 µL) saturated bromophenol blue was added to this mixture to make 
the lanes visible when loading samples. In both cases, the solution was also degassed and 
polymerized by using 10% APS and TEMED. 
Added to the sample were 4x loading dye (40% glycerol, 250 mM Tris-HCl pH 6.8, 8% 
SDS, 0.04 mg/mL bromophenol blue, 5% βME and 100 mM EDTA) to make a final 
concentration of 1x.  The samples were boiled, loaded and run at 200 volts while the gel 
apparatus was attached to a water cooling system. Gels were run for about 2 hours or until the 
blue front reached the bottom. 
2.2.5 Sample preparation for NMR investigation 
Samples being prepared for NMR require a special experimental buffer made up of salt 





within the lock frequency of the spectrometer (Roberts, 1993b, Wüthrich, 1986). The labeled 
iNOS peptide bound to unlabelled CaM was in Tris buffer therefore a buffer exchange was 
required. The 15 mL 3 kDa Viva spin column was loaded with the protein solution and 
concentrated to 500 µL. The flow through was discarded and the NMR buffer (100 mM KCl, 10 
mM CaCl2, 0.2 mM NaN3, pH 6.0 no adjustment) was added to the 10 mL mark on the spin 
column and concentrated again to 500 µL, which takes about two hours.  This process was 
repeated five times to ensure all traces of Tris buffer were gone. For the final spin, the sample 
was concentrated down to 450 µL so that a 50 µL addition of D2O can be added for a final 10% 
D2O composition. The final concentration was 500 µL of ~1.4 mM protein. The sample was 
transferred into a NMR 5 mm, 7‟‟ sample tube and stored at 4
o
C until required for NMR 
experiments. 
2.2.6 NMR experiments 
2.2.6.1 iNOS CaM-binding region 
The prepared sample was analyzed on Bruker 600 or 700 MHz NMR spectrometers 
according to standard setting for the specific NMR experiment being run (see Appendix B). All 
experiments were run by Dr. Thorsten Dieckmann. NMR experiments performed on the peptide 
were 
15
N-HSQC, HNCA, CBCAcoNH and a 3D 
15
N-NOESY.  The spectra were visualized and 
assignments were made using Computer Aided Resonance Assignment (CARA) version 1.8.4, 
2007 (Keller, 2004). 
2.2.6.2 CaM 
The expression and purification of CaM produced peptide-free holo-CaM but we wanted 





iNOS peptide (Sigma-Aldrich) was titrated into the CaM NMR solution. The synthetic iNOS 
peptide was prepared by dissolving the powdered peptide in water to produce a concentration of 
1 mM, aliquot into 200 µL and 100 µL fractions in 0.5 mL Eppendorf tubes and then lyophilized. 
For the best 1:1 binding ratio, the HSQC spectrum was used to monitor the disappearance of the 
free CaM peaks and the appearance of the peaks of CaM in complex with iNOS CaM-binding 
region with each addition of lyophilized iNOS peptide. The final saturated sample was used to 
run the rest of the NMR experiments using the Bruker 600 or 700 MHz NMR 
spectrophotometers. The majority of the NMR experiments for the CaM protein were acquired in 
2007 and 2008 by Dr. Thorsten Dieckmann and Don Spratt (PhD, 2008, UW). The experiments 
obtained for isotope labeled CaM bound to the unlabeled peptide of the iNOS CaM-binding 
region were 
15
N-HSQC, HNCA, CBCAcoNH, HNCOCA, HCcH-TOCSY and NOESY. The 
spectra were visualized and assignments were made using Computer Aided Resonance 
Assignment (CARA) version 1.8.4, 2007 (Keller, 2004). 
2.2.6.3 NMR spectra assignment strategy 
The assignment of a protein starts with the 
15
N-HSQC spectrum which shows the 
backbone amide protons and nitrogen as well as the amides in the side chains of amino acids. 
The spectrum is opened in SynchroScope using CARA. SynchroScope is one of the viewing 
modes in CARA that allows for easy backbone assignments. The main window contains the 
HSQC spectrum where at each hydrogen-nitrogen chemical shift, corresponding carbon peak(s) 
in the 3D experiments will be shown in the strip window. In the strip window of synchroscope 
mode, 3D NMR experiments such as HNCA, HNcoCA and CBCAcoNH can be opened. These 
3D NMR experiments correlate the H-N of amino acid „i‟ on the HSQC to a Cα of amino acid „i‟, 





observed peak in the HSQC spectrum a peak number.  In the strip window, HNCA will give two 
peaks with one larger than the other.  The larger peak was assigned to the Cα(i) and the smaller 
one to the Cα(i-1).  The Cα(i-1) assignment was confirmed using the HNcoCA and CBCAcoNH 
spectra since they both contain the Cα(i-1). The CBCAcoNH also contains the peaks for Cβ(i-1). 
Once all possible peaks were assigned to H, N, Cα(i), Cα(i-1) and Cβ(i-1), the HNCA is opened in 
StripScope mode where each strip shows the Cα(i) and Cα(i-1) peaks assigned in SynchroScope 
which correspond to a backbone amide. Connecting residues can be determined by finding best 
matches of Cα(i) and Cα(i-1) in different strips by using the function select strips - all best 
precursor or - all best successor. This function aligns all best carbon chemical shifts for the 
preceding or subsequent amino acid (Figure 2.4B). By using amino acid residues in the sequence 
that have unique carbon chemical shifts, such as alanine, glycine and threonine, the peak number 
can be assigned to an amino acid residue. These unique amino acids are then used as starting 
points for assigning peaks to the protein sequence; and knowing the expected amino acid 
adjacent to these unique amino acids can confirm whether preceding or subsequent amino acid 






Figure 2.4. Sequential assignments of protein using HSQC, HNCA, HNcoCA and 
CBCAcoHN. 
In the CARA, using the SynchroScope viewing mode to open the (A) HSQC spectrum in the 
main window that contains correlation peaks between the nitrogen and proton of an amide. For 
each NH correlation, there are correlation peaks to the alpha carbons of the same amide amino 
acid and of the preceding amino acid and the beta carbon of the preceding amino acid as seen in 
the 3D experiments, HNCA, HNcoCA, and CBCAcoNH.  These 3D experiments are viewed in 
the Strip window of SynchroScope. (B) The preceding carbon shift can be used to determine the 
NH correlation peak it belongs to.  This process was done using the StripScope viewing mode by 
lining the preceding carbon peak of one strip to the alpha carbon of another strip.  
After the backbone assignments, the side chains of the amino acids are assigned using the 
15
N-edited HSQC-TOCSY and NOESY spectra. These two spectra are opened in PolyScope 
mode where you can move along the nitrogen planes in the strip window.  At each nitrogen plane 
that corresponds to an amide backbone, the protons of the side chain (TOCSY) and protons that 
are within 5Å (NOESY) will be present as well as cross peaks between neighboring amide 
protons. The assignment of the TOCSY peaks will help identify which peaks in the NOESY are 





2.3 Results  
2.3.1 iNOS CaM-binding region expression and purification  
During the optimization of the intein recombinant iNOS CaM-binding region (intein-
iNOS peptide), various induction temperatures and protein expression periods were tested to 
determine their effect on expression level and solubility. Results of the different trials and the 
final yield of iNOS CaM-binding region are summarized in Table 2.2.  
Table 2.2. Summary of expression and purification results of iNOS CaM-binding region.  




 from 2L of minimal 
media  




C induction for 
6 hrs  
~ 0.025 mM (750 µL)  
Intein-iNOS peptide with 





C induction for 
6 hrs  
~ 0.03 mM (750 µL)  
Refolding of intein-iNOS 





C induction for 
6 hrs  
None 
No self-cleavage  
Intein-iNOS peptide with 





C induction for 
12 hrs  
~ 0.42 mM (500 µL)  
Intein-iNOS peptide with 





C induction for 
20 hrs  
~ 0.84 mM (500 µL)  
a 
Yield was determined using the Lowry method using wild-type CaM as the standard 
Results that will be shown are those of the refolding of intein-iNOS peptide using the 
drip-wise dialysis method and the method used to produce the iNOS CaM-binding region for 
NMR experiments.  
a) Results of purification iNOS peptide from inclusion bodies 





C isotopes. Protein expression was good producing a large portion of protein in 
the insoluble fraction in the pellet after cell lysis and centrifugation. 8 M urea was able to 
solubilize the majority of the pellet with a small precipitate remaining, which was separated from 





step to help keep the iNOS peptide portion soluble once protein started to refold, since it was 
seen that, at 7 M urea, a large amount of protein precipitated out of solution. During the drip-
wise dialysis to reduce the urea concentration, precipitate that formed was removed before 
continuing to the next concentration. Samples from the precipitate and soluble fraction showed 
the proportion of soluble to insoluble intein-iNOS peptide was reduced during each step of the 
drip-wise urea reduction (Figure 2.5). By the refolding buffer less than a quarter of the protein 
was found to be soluble. The soluble protein that remained in solution was used to load onto the 
chitin bead column but during the elution process, no proteins were eluted. 
 
Figure 2.5. 10% SDS-PAGE of intein-iNOS peptide solubility in refolding process. 
The solubility of sample during the drip-wise dialysis was analyzed by comparing the 
supernatant and the pellet at each urea concentration since precipitate was seen at each dialysis 
level. Samples from supernatant collected at 8, 6, 4, 2 and 1M urea as well as in the refolding 
buffer (lanes 2, 4, 6, 8, 12 and 15 respectively) were compared to their soluble counterpart (lanes 
3, 5, 7, 9, 13 and 16 respectively). Low molecular marker (Lanes 1, 11 and 14) was used to 
monitor the position of intein-iNOS peptide located at ~60 kDa and CaM at 17 kDa.  
 
b) Result for intein-iNOS soluble protein  
A 2 L culture of fresh ER2566 competent cells transfected with pTYB12-iNOS peptide 




C isotopes resulted in a cell pellet 





The expression of the CBD-intein-iNOS peptide protein was confirmed running a 10% SDS-
PAGE (Figure 2.6) prior protein purification. The CBD-intein-iNOS peptide protein can be seen 
faintly at about 60 kDa in the red box after 22 hours of induction, which was not observed at 
time 0.  
 
Figure 2.6. 10% SDS-PAGE gel used to confirm expression of CBD-intein-iNOS peptide 
protein  
Two flasks were grown for each 1 L culture. Lanes 1 is the uninduced and lane 2 is the induced 
sample after 20 hours from flask 1. Lanes 3 and 4 are the uninduced and induced (taken at 22 
hours) respectively for flask 2. For lane 1 to 4, gel sample was prepared using the pellet from 1 
mL sample taken from the minimal media at time 0 and 20 hours and resuspended in 2x SDS 
sample loading buffer according to the sample‟s optical density at 600 nm. For every 1 OD600 of 
the sample, the pellet was resuspended in 100 µL of loading buffer. Lane 5 is the low molecular 
marker to monitor the expression of the ~60 kDa CBD-intein-iNOS peptide. 
During the purification process, samples from each step were taken and run on a 10% 
SDS-PAGE gel as a precautionary measure before continuing with the purification process. The 
majority of proteins produced were soluble, which was verified by the large band at 60 kDa in 
the supernatant lane of Figure 2.7. The CBD of the fusion tag was tightly bound to the chitin 
beads since no CBD-intein-iNOS peptide band was seen in the flow through or wash (Figure 2.7, 





flow through lane at ~17 kDa. Therefore the CaM found in the subsequent steps of the 
purification process is CaM that is tightly bound to the iNOS CaM-binding region. 
 
Figure 2.7. 10% SDS-PAGE analysis of the purification process for the CBD-intein-iNOS 
peptide before eluted from the chitin beads. 
The monitoring of protein content of each step during the purification. 1) Low molecular marker. 
2) Homogenized sample taken after the resuspended cell pellet was lysed by the emulsifier. After 
centrifugation samples were taken from 3) the pellet and 4) the supernatant to determine the 
solubility of the protein. 5) Sample taken from flow through when the supernatant was passed 
through the chitin column. 6) Sample from the flow through during the wash step of the column. 
The CBD-intein-iNOS peptide band is located at ~60 kDa, red box, and can be seen in the lanes 
2,3, and 4. The ~17 kDa CaM band is seen slightly in the lanes 2-5. This gel shows the CBD-
intein-iNOS peptide was soluble and adhered to the chitin column. 
Elution of the CaM-iNOS peptide by incubating the column in 50 mM DTT initiated the 
self-cleavage of the intein as described in section 2.2.3.  Each 2 mL fraction was run on a 16.5% 
Tris-Tricine SDS-PAGE gel (Figure 2.8) to determine which fraction contained the CaM-iNOS 
peptide. In an SDS-PAGE analysis, the complex formed by the CaM and the iNOS peptide 
dissociates under the denaturing condition and is seen as two separate bands, 17 kDa for CaM 
and ~4 kDa for iNOS peptide (Figure 2.8). According to the gel analysis of the elution process, 
about 5 mL eluted material was collected before the CaM became visible and continued to 





fraction 12 indicated proteins were still present on the column. Fraction 3 to 15 were pooled and 
concentrated using the Viva spin column with a 3 kDa molecular weight cut off. 
 
 
Figure 2.8. 16.5% Tris-tricine SDS-PAGE analysis of the eluted fractions from the chitin 
column. 
The fusion protein bound to the chitin resin was incubated for 48 hours in buffer containing 50 
mM DTT. Elution of the CaM-iNOS peptide was monitored using SDS-PAGE. 3 µL from each 
of the 2 mL fraction were used for the analysis. Lane 1 is the low molecular marker. Lane 2-13 
represents fractions 1-12 respectively. All fractions contained some CaM-iNOS peptide, but 
fractions in lane 3-13 were pooled as well as additional 6 mL eluted after lane 13. 
 Some large molecular weight contaminants were seen in Figure 2.8, fraction 12 and were 
more apparent when the sample was concentrated; therefore gel filtration was employed to 
remove these proteins as well as residual DTT that was not removed during the concentration 
step. The results from the gel filtration chromatography step using Superdex 70 10/300 are 
shown in Figure 2.9. A SDS-PAGE (Figure 2.9B) run on samples eluted from the gel filtration 
column showed that the large molecular proteins were removed and a mass spec was run to 







Figure 2.9. 16.5% Tris-Tricine gel analysis of the CaM-iNOS peptide elution from the 
Superdex 75 10/300 column. 
The A) gel filtration profile zoomed in to where the high molecular weight protein contamination 
and CaM-iNOS peptide peaks were eluted off the column. The high molecular contaminants 
were eluted off in fraction A5 to A10 and the elution of the CaM-iNOS peptide was eluted in 
fractions B3 to B5.  B) A gel was run on to the CaM-iNOS peptide fractions, B2-B9, and it was 
found that fraction B4-B8 had the majority of the protein.  
Protein quantification by the Lowry method showed a yield of 500 µL of 1.2 mM of 
iNOS that was purified from a culture grown in 4 L minimal media.  A buffer exchange into 
NMR sample solution describe in section 2.2.5 was performed and placed in NMR sample tube 
and stored at 4
o
C.  
2.3.2 NMR spectra and assignments 
2.3.2.1 iNOS CaM-binding region 




N isotopically labeled iNOS peptide in complex 
with unlabelled CaM were run on the Bruker 700, except for the 
15
N-edited HSQC-NOESY 
which was run on the Bruker 600. The first experiment was the HSQC (Figure 2.10) which was 
checked for the possible twenty-seven peaks produced by the peptide. About twenty-six peaks 





2.2.5.3, there were many H-N peaks that had no corresponding peaks in the HNCA or 
CBCAcoNH spectra.  On the other hand, there were a few peaks, 16 and 31, that had 
corresponding carbon peaks in the 3D spectra but had a very weak peak in the HSQC. These 




Figure 2.10. HSQC spectrum of isotopically labeled iNOS peptide bound to unlabeled CaM 
with partial peak assignments. 
This spectrum was run on the Bruker 700. The iNOS peptide peak assignments show the 
correlation between the amide and their proton. Most peaks have been assigned to amino acid 
residues but the few with just numbers have not yet been assigned or have some ambiguities.  
The spectrum was analyzed using the CARA NMR visualizer.  
 For the peak numbers that were assigned to amino acid residues, three-dimensional NMR 
experiments such as HNCA and CBCAcoNH were used to determine connection between 
sequential residues of the iNOS peptide. The NOESY spectrum was able to confirm these 
backbone assignments (Figure 2.11). However, the connection through space (NOE) between the 
side chain and of other side chains that are within 5 Å could not be confidently assigned without 





spectrum enables the intermolecular peaks in the NOESY to be identified. The intermolecular 
peaks can help in the prediction of secondary structures. In the NOESY spectrum some 
noticeable NOE peaks could be determined (Figure 2.11) belonging to the proton of the alpha 
carbons. The peaks of these alpha carbons are correlated with the amide proton two and three 
residues away which are characteristics of an α-helix (Roberts, 1993a, Wüthrich, 1986). But to 





N-NOESY of iNOS peptide. 
NOESY stripes of sequential amino acid Val15 to Cys24 of the iNOS peptide. The connection 
between the amide protons of the previous and successor residue are shown in the bottom half of 
the spectra in burgundy. Protons of the alpha carbon of a few residues, L16, V17 and L21, are 
assigned. The peaks corresponding to these protons appear in the spectrum of amino acids that 
are three residues away, shown in the upper portion of the spectrum in red. These NOE 
connections are indicative of an α-helix secondary structure.  
The backbone assignment of amino acid residues assigned for the iNOS CaM binding 
domain at this point is highlighted in red below and is also shown in Figure 2.12. Lists of 





AGHMR PKRRE IPLKV LVKAV LFACM LMRK 
 
Figure 2.12. Crystal structure iNOS CaM-binding region showing the assigned amino 
acids. 
The structure shows the helical conformation of iNOS CaM binding region, glutamine 512 to 
lysine 531. Highlighted in red, are the amino acids that have been assigned (leucine 515 to lysine 
531). Structure made from the newly published crystal structure of iNOS FMN-CaM binding 
region bound to CaM, PDB 3HR4 using Accelrys DS visualize v2.5.1. 
 The sequence of the iNOS peptide begins at the blue amino acid residues. Therefore the 
majority of the amino acids that have not been assigned belong to the extra residue left over from 
the intein cleavage and the NdeI cut site. The unassigned region (blue residues) is separated from 
the assigned region by a proline. Because a proline does not have an amide peak in the HSQC, 
the sequential backbone assignment strategy using the information from the assigned area could 
not be used. Nitrogen-proton correlation for the unassigned residues could not be assigned to a 
peak number in the HSQC. Free peak numbers, which are peaks not assigned to an amino acid 
residue on the iNOS peptide, did not show backbone connection with other free peak numbers. 
Therefore these residues remain unassigned to a peak number. 
2.3.3 NMR experiments on CaM 
The titration of the synthetic iNOS peptide of the CaM-binding region into the CaM 
NMR solution used two 200 µL and one 100µL of the 1 mM lyophilized peptide stock. The 
HSQC spectrum ran after each addition showed the progress of the titration by comparing the 





(Figure 2.13). Once all the free CaM peaks were gone, it can be assumed a 1:1 binding ratio 









Figure 2.13. Overlay of HSQC spectra of CaM being titrated with iNOS peptide   
The initial HSQC spectrum of CaM (colour aqua) was overlaid with the spectrum of different 
ratios of iNOS peptide to Ca
2+
-CaM. The ratios are 1:3 ratio (blue), 2:3 ratio (purple) and 1:1 
ratio (red). (a) The HSQC spectra show amino acid residues in calmodulin with the assignments 
belonging to the peptide-free CaM. The two lower images (b & c), demonstrate the chemical 
shifts of the amino acids, G33 and N137, as the iNOS peptide saturation levels increased. Spectra 
produced from Bruker 600 spectrophotometer and image was made using CARA, version 1.8.4. 
During the titration process of Ca
2+
-CaM with iNOS peptide, two distinct peaks 
corresponding to the free Ca
2+
-CaM and peptide bound Ca
2+
-CaM were observed such as in 





of the bound CaM was stronger. This pattern indicates a slow exchange regime between the two 
states and therefore the interaction between the iNOS peptide and CaM is tight binding (Reid, 
1997).  
For the backbone assignment, the strategy in section 2.2.5.3 was used where each peak in 
the saturated CaM HSQC spectrum was assigned a peak number. An additional method was used 
in conjunction with the previous method since CaM contains more amino acid residues than the 
iNOS peptide. The NMR peak list of free holo-CaM is available on the Biological Magnetic 
Resonance Bank (BMRB) website as BMRB 6541 and was used to assign the peptide free holo-
CaM. Using the results from the HSQC from the iNOS peptide titration (Figure 2.13), some 
amino acid residues were assigned and used as assigning starting points. The majority of these 
starting points were of amino acids outside the cluster of peaks located in the middle of the 
spectrum where some ambiguities can arise. In most cases peaks in the cluster could be assigned 
if they lined up well in the StripScope function (Figure 2.14), where D20 and D24 are located in 
the cluster.  
 
 
Figure 2.14. The amino acid fragment, phenylalanine 19 to theronine 28, of CaM alpha 
carbon alignment and overlapping using the HNCA spectrum in StripScope view. 
Each strip presented is at a specific nitrogen and proton correlations plane and the peaks 






Currently about 60% of the backbone assignments have been completed (Appendix D). 
The main area of assignments is in the EF hand regions whereas the central linker region has yet 
to be accurately assigned. In Figure 2.15, the highlighted regions are the areas that have been 
assigned. 
 
Figure 2.15. Crystal structure of CaM showing residues with NMR assignments. 
The yellow highlighted areas are the amino acids that have their backbone (H, N, Cα and Cβ) 
assigned to the NMR data. The EF hand regions are located near the four Ca
2+
 ions (green 
sphere). The centre linker region, the large α-helix, joining the N-terminal lobe (blue) to the C-
terminal lobe (red), has yet to be assigned. 
Based on the current backbone assignments, a comparison of CaM chemical shifts in its 
unbound form and its peptide bound form (Figure 2.16) shows a slightly larger change in the N-
terminal lobe of CaM than the C-terminal lobe. The greatest changes in overall chemical shifts 
are MET36, ILE63 and ARG106. These amino acids belong to the region just after an EF hand 
loop where Ca
2+
 binds. The central linker region has not been assigned, but based on the failed 
attempt to locate the movement of their peaks using the titration spectra it can be assumed that 





































Amino acid residue number 
Figure 2.16. Differences in free Ca
2+




The proton and nitrogen chemical shift of amides belonging to amino acid residues of Ca
2+
-CaM 
bound to iNOS peptide whose backbone have been assigned are compared to the chemical shift 
of unbound Ca
2+
-CaM. (A) The differences between the proton, (B) nitrogen and (C) overall 
differences. The equation ∆𝛿overall  =  (∆δH)2 +  (∆δN ∙
γN
γH
)2   (Cui et al., 2003) was used to 
calculate the overall differences in chemical shift. The secondary structure above the graphs 
shows the location of residue number (undulations are helix, straight lines are random coil and 





















2.4 Discussion  
In nature iNOS is always found bound to CaM and the in vitro production of recombinant 
holo iNOS requires CaM to be co-expressed, indicating iNOS requires CaM for activation as 
well as stability. Even though the iNOS CaM-binding region is just two percent of the whole 
protein and technically twenty-four amino acids long, the extremely hydrophobic properties 
make it unstable in solution resulting in aggregation. The attempt to refold the intein-iNOS 
peptide in the inclusion bodies resulted in a lack of intein cleavage, which most likely was due to 
the incorrect refolding of the intein portion. The best method obtained in this investigation was 
the expression with the CBD-intein fusion tag and with a low induction temperature of 15
o
C for 
a period of 22 hours. The fusion tag being 55 kDa in size allows for monitoring of protein 
expression and provides an easy method of purification. At lower temperatures, hydrophobic 
interactions are reduced and protein production rates decrease. These properties increases the 
probability of polypeptides forming proper secondary structure without interacting with their 
misfolded neighbours (Vaillancourt, 2003). The induction period was increased from the original 
six hours to twenty hours due to better levels of expression and yields of soluble protein. 
Reducing the induction temperature to 15
o
C shocks the E. coli cells and the rate of translation 
decreases therefore a longer induction period is required for production of proteins (Vaillancourt, 
2003). 
CaM and the iNOS CaM-binding region peptide could not be co-expressed since there‟s 
no method of selective isotope labeling when two proteins share the same growth medium.  
Eventually the addition of CaM would be required since we wanted the structure of the iNOS 
peptide when bound to CaM. The addition of CaM during the lysis step resulted in higher yields 





CaM and reduce the amount of free peptides available for aggregation.  The addition of CaM 
also facilitated iNOS peptide detection after the fusion tag was cleaved off. The final yield from 
a 4 L culture grown in minimal media was 500 µL of 1.2 mM of purified protein. 
The assignment of the NMR peaks for the iNOS CaM-binding region was much easier 
than that of the CaM since there is a significantly smaller number of amino acids to assign and 
less overlap of the peaks. The final structure was not obtained but the majority of the iNOS 
residues have their amino acid backbone assigned. Some analysis from the NOESY spectrum 
shows peak correlation between alpha protons of amino acid „i‟, and the N-H of amino acid 
„i+1‟, „i+2‟ and possible „i+3‟ which is a pattern characteristic of α-helices (Roberts, 1993a, 
Wüthrich, 1986). Since the TOCSY spectrum has yet to be run, the peaks of the amino acid side 
chain cannot confidently be distinguish from those peaks of adjacent amino acids or those within 
5 Å.  
The assignment of the NMR peaks for CaM has proven to be challenging especially in 
the region with large clusters of overlapping peaks in the HSQC and the amino acids in the 
central linker region. For the cluster and the centre linker region, there have been no easy start 
points that could be derived from the CaM titration spectra that did not end in false assumptions 
or lack of verification from the 3D spectra. The amino acid backbones of the EF hands were 
assigned with confidence, since the EF hands have a conserved amino acid pattern that contains 
glycines alternating with asparagines. Verification of sequential amino acids was simplified due 
to the lack of a beta carbon peak in glycine seen in the CBCAcoNH spectrum. The assignment of 
the EF region can provide some information on the behavior of the N-terminal and C-terminal 
lobes of CaM. The larger chemical shift changes in the N-terminal lobe indicate it is affected 





more readily with the iNOS peptide (Cui et al., 2003). The binding affinity of iNOS to CaM is 
classified as tight-binding with dissociation constant of 1.5 nM (Venema et al., 1996) which is 
supported by the data from the HSQC titration that show slow-exchange between peaks of free 
CaM and bound CaM.  
During this study a crystal structure of the human iNOS FMN domain intact with the CaM-
binding region (FMN-CaM binding region) was solved with a resolution of 2.5 Å (Xia et al., 2009). In 
one crystal, they were able to determine four different conformations of the FMN-CaM binding region 
bound to CaM with the aid of  known structure of the FMN domain from nNOS reductase domain 
(Garcin et al., 2004). Using the crystallography software Phaser and some model rebuilding and 
adjustment, they were able to locate and compose the four different conformations of the FMN-CaM 






















Figure 2.17.Crystal structures of the iNOS FMN domain and the CaM binding region with 
CaM bound to it. 
The four structures solved by Xia, et al. (2009) were superimposed by aligning the CaM binding 
domain to show the range of motion of the FMN domain. (a) Shows all four structures 
superimposed with Ca
2+
(yellow sphere)-bound CaM (orange) wrapped around the CaM-binding 
region. (b)-(d) Compares the movement of each structure with respect to the purple structure 
with the bound CaM removed. (b) has the least amount of movement and (d) the largest. The 
FMN cofactor of the purple structure is shown as ball and stick figure. Structures were made 
from PDB 3HR4 using Accelrys DS visualize 2.5. 
It can be seen that the FMN domain does move towards the expected position of the 
heme donor. In Figure 2.17d, the distance change of the two structures (purple and pink) was 
measured to be 22 Å when using residue Asp595, which is located near the FMN cofactor. If the 
large FMN shift was proposed to be a 55 Å shift by Garcin et al. (2004), then this 22 Å 
difference shows that the FMN domain is dynamic but it only shows half of the possible 
movement. However, an important flexible hinge region was found located at Arg536 at the end 
of the CaM-binding region. This amino acid is fully conserved in all three isoforms and is 





 The CaM bound to this crystal structure exhibited relatively similar conformation with 
crystal structures of the other isoforms (Figure 2.18).  The iNOS peptide was found to bind in an 
antiparallel manner as was predicted by Spratt et al. (2007b) and forms an α-helix, which 
confirms some of the NOE in the NOESY spectrum (Figure 2.11). The reported crystal structures 
show that there are some major differences that contribute to the tight binding between the iNOS 
peptide and CaM. The N-terminal lobe of CaM binds at a closer proximity to the iNOS peptide 
than the other isoforms (Figure 2.18) which could explain the larger change in chemical shift of 
the N-terminal lobe seen in our NMR data (Figure 2.16).  The largest change was found for 
Met36 and Ile63 in the N-terminal lobe and the amino acids that they interact with on the C-
terminus of the iNOS peptide are shown in Figure 2.19. Met36 and Ile63 interact with key 
hydrophobic amino acids in the iNOS peptide such as Leu528 which is one of the anchoring 
amino acid residues. Flanking each side of Leu528 are Met residues that add in the tighter 
binding to the N-terminal lobe of CaM. Arg106 also showed a large change in chemical shift but 
examining the location of this residue indicated no interaction with amino acid on the iNOS 
peptide. Instead it points away from the cavity of the iNOS peptide towards the solvent.  
   
Figure 2.18. Crystal structure of eNOS, nNOS and iNOS CaM-binding region bound to 
CaM 
Comparison of the CaM binding region of the three isoforms (gold) in complex with CaM (blue 
and red which represent N- and C-terminal lobes, respectively). The cNOS enzymes are very 
similar whereas iNOS has CaM more tightly wrapped especially in the N-terminal. The centre 
linker region is also not as extended as the other isoforms. Figure made from 1NIW, 2O60 and 








Figure 2.19.  Met36 and Ile63 of CaM interacting with the C-terminal of the iNOS peptide. 
Methionine 36 and isoleucine 63 are shown as ball and stick figure branching from the blue 
ribbon structure of the N-terminal lobe of CaM. The amino acids that they interact with are 
indicated by green lines connecting the two residues. Met36 interacts with Met527 (4.095 Å) and 
Leu528 (4.969 Å) on the iNOS peptide whereas Leu63 interacts with Leu528 (5.282 Å) and 
Phe524 (4.384 Å) through hydrophobic interactions. Figure made from PDB 3HR4 (Xia et al., 
2009) using Accelrys DS visualize 2.5. 
The structure of the iNOS FMN domain with the CaM binding region is the first 
structural evidence of movement in the FMN domain. Xia et al (2009) went further and 
superimposed the FMN of the iNOS onto the FMN site of the existing crystal structure of nNOS 
reductase domain to create a model for electron transfer from the FAD to the heme. Based on 
this model, they were able to determine that the FAD, FMN and the CaM have very little contact 
during the electron transfer. This point indicates the three partitions are flexing away from each 
other and that there must also be another hinge region connecting the CaM binding domain and 
the heme region (Xia et al., 2009). When the oxygenase domain and the dimer were accounted 
for in the model, the FMN domain interface had the most contacts with the oxygenase domain of 





The new published structure shows some of the dynamic properties of the FMN domain 
and an insight into factors contributing to the tight binding of CaM to iNOS. The results obtained 
so far from our NMR investigation of iNOS CaM-binding region have been supported by this 
crystal structure particularly in the CaM-binding region. As the assignments of the NMR spectra 





Chapter 3 Future Work 
 Once the backbone or full assignments of CaM have been completed, another aspect that 
can be examined is the effect that posttranslational modification of calmodulin has on the 
interactions with the NOS CaM-binding region. Calmodulin in vivo can be regulated in many 
ways such as phosphorylation, oxidation and by interaction with small peptides (Benaim and 
Villalobo, 2002). These modes of regulation can alter CaM‟s structure and methods of 
interaction with target proteins that may result in inhibiting the binding of CaM or reducing 
enzyme function (Benaim and Villalobo, 2002).  Mode of regulation of interest is 
phosphorylation which occurs at specific tyrosine residues on CaM. To study phosphorylation of 
these sites, selected tyrosine residues were mutated to aspartic acid or glutamic acid, which 
mimicked the electrostatics properties of phosphorylated residues (Spratt et al., 2008). Kinetic 
assay studies in our lab have found  that tyrosine 99 mutated to aspartic acid had a significant 
reduction in enzymatic activity (Israel, 2010). Therefore examining the effects of T99Y on the 
structure of CaM and how it interacts with the iNOS peptide using NMR spectroscopy will show 
what is occurring on the structural level. The full backbone assignment of wild-type CaM bound 
to the iNOS CaM-binding region in the HSQC spectrum can be compared to the HSQC of the 
mutant CaM. Factors to look for are peak shifts of the mutated amino acid(s) in adjacent amino 
acids and in the immediate area.  
Another side project is the NMR experiments which have been acquired for CaM 
interaction with iNOS CaM binding domain, which have been shared with Ming Li, a researcher 
in the UW Math department whose group is currently writing a program to automatically assign 
NMR spectra of CaM. Collaboration with one of Dr. Li‟s students, Richard Yang, has required 





Future work with this group will aid in faster assignments of mutant CaMs and CaM bound to 
other NOS isoforms. 
The dynamics of the FMN domain and further characterization of the effects induced by 
CaM can be done using NMR spectroscopy. NMR spectroscopy can provide a family of best fit 
structures that can show the range of movement using spin relaxation experiments to determine 
changes in chemical shift and the exchange rate in a period of time (Wüthrich, 1986). The 
methods used in the solved structure of the FMN domain by (Xia et al., 2009), can also aid in 






Appendix A – Mass Spectrometer result of CaM bound to iNOS CaM-binding 
region 

















Appendix B – NMR file location and pulse sequence 
 
HSQC: 




;2D H-1/X correlation via double inept transfer 
;   using sensitivity improvement 
;phase sensitive using Echo/Antiecho-TPPI gradient selection 
;with decoupling during acquisition 
;using trim pulses in inept transfer 
;using f3 - channel 
; 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, J. Biomol. NMR 4, 
;   301-306 (1994) 
 
HNCA: 




;3D sequence with 
;   inverse correlation for triple resonance using multiple 
;      inept transfer steps 
; 
;      F1(H) -> F3(N) -> F2(Ca,t1) -> F3(N,t2) -> F1(H,t3) 
; 
;on/off resonance Ca and C=O pulses using shaped pulse 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho gradient selection (t2) 





;(use parameterset HNCAGP3D) 
; 
;S. Grzesiek & A. Bax, J. Magn. Reson. 96, 432 - 440 (1992) 
;(J. Schleucher, M. Sattler & C. Griesinger, Angew. Chem. Int. Ed. 32, 
;   1489-1491 (1993)) 










;3D sequence with 
;   inverse correlation for triple resonance using multiple 
;      inept transfer steps 
; 
;      F1(H) -> F3(N) -> F2(C=O) -> F2(Ca,t1)  
;            -> F2(C=O) -> F3(N,t2) -> F1(H,t3) 
; 
;on/off resonance Ca and C=O pulses using shaped pulse 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho gradient selection (t2) 
;using constant time in t2 
;(use parameterset HNCOCAGP3D) 
; 
;S. Grzesiek & A. Bax, J. Magn. Reson. 96, 432 - 440 (1992) 









;3D sequence with 
;   inverse correlation for triple resonance using inept transfer steps  
; 
;      F1(H) -> F2(Caliph.,t1 -> Ca) -> F2(C=O) -> F3(N,t2) -> F1(H,t3) 
; 
;on/off resonance Ca and C=O pulses using shaped pulse 
;phase sensitive (t1) 
;phase sensitive (t2) 
;using constant time in t1 
;using constant time in t2 
;water suppression using watergate sequence 
;(use parameterset CBCACONHGPWG3D) 
; 
;S. Grzesiek & A. Bax, J. Biomol. NMR 3, 185-204 (1993) 






# 1 "C:/Bruker/XWIN-NMR/exp/stan/nmr/lists/pp/invifpf3gpsid31" 
;invifpf3gpsi 
;avance-version 
;2D H-1/X correlation via double inept transfer 





;phase sensitive using Echo/Antiecho-TPPI gradient selection 
;with decoupling during acquisition 
;using f3 - channel 
;using flip-back pulse 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, J. Biomol. NMR 4, 
;   301-306 (1994) 
;S. Grzesiek & A. Bax, J. Am. Chem. Soc. 115, 12593-12594 (1993) 









;3D sequence with 
;   homonuclear correlation via dipolar coupling  
;   dipolar coupling may be due to noe or chemical exchange. 
;   H-1/X correlation via double inept transfer 
;      using sensitivity improvement 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho-TPPI gradient selection (t2) 
;using trim pulses in inept transfer 
;with decoupling during acquisition 
;using shaped pulses for inversion on f2 - channel 
;(use parameterset NOESYHSQCETGP3D) 
; 
;A.L. Davis, J. Keeler, E.D. Laue & D. Moskau, J. Magn. Reson. 98,  
;   207-216 (1992) 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114, 
;   10663-5 (1992) 








;3D sequence with 
;   homonuclear correlation via dipolar coupling 
;   dipolar coupling may be due to noe or chemical exchange 
;   H-1/X correlation via double inept transfer 
;      using sensitivity improvement 
;phase sensitive (t1) 
;phase sensitive using Echo/Antiecho-TPPI gradient selection (t2) 
;with decoupling during acquisition 
;using flip-back pulse 
;using f3 - channel 
;(use parameterset NOESYHSQCFPF3GPSI3D) 
; 
;O. Zhang, L.E. Kay, J.P. Olivier & J.D. Forman-Kay,  
;   J. Biomol. NMR 4, 845 - 858 (1994) 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. Schmidt, O. Schedletzky, 














;3D sequence with 
;   inverse correlation using multiple inept transfer and 
;      C-C DIPSI3 spinlock 
; 
;      F1(H,t1) -> F2(C,t2) -> F2(C') -> F1(H',t3) 
; 
;off resonance C=O pulse using shaped pulse 
;phase sensitive (t1) 
;phase sensitive (t2) 
;spinlock during z-filter 
;(use parameterset HCCHDIGP3D) 
; 
;(L.E. Kay, G.Y. Xu, A.U. Singer, D.R. Muhandiram & J. D. Forman-Kay 








Appendix C – iNOS Peptide Assigned Chemical shift  
Peak # A.a # HN Cα N 
1 L 13 10.244 55.558 128.211 
2 L 21 8.89 56.253 121.099 
3 K 14 8.844 56.947 114.853 
4 V 17 8.689 64.213 111.605 
5 C 24 8.538 61.395 114.936 
6 M 25 8.493 56.173 120.181 
7 A 19 7.778 53.176 120.248 
8  8.433 53.368 123.329 
9  8.365 51.258 123.7 
10  8.285 55.585 122.852 
11  8.266 53.047 122.736 
12  7.903 54.116 122.584 
13  8.334 52.673 121.624 
14  8.286 53.587 121.463 
15 R 28 8.029 53.341 122.102 
16  8.348 52.887 118.363 
17 V 20 8.275 64.48 116.528 
19 F 22 7.925 58.87 118.491 
20 L 16 7.784 55.366 120.332 
21 K 29 7.91 54.81 127.772 
22 A 23 7.665 52.78 117.515 
23  7.469 40.533 120.347 
24  7.318 40.541 120.333 
25 M 27 7.239 54.196 116.892 
26 L 26 7.163 52.994 117.793 
28 K 18 7.143 57.829 119.476 
29  7.083 40.707 119.89 
30 V 15 6.755 63.212 117.347 
31  8.054 50.85 121.067 
















Appendix D - CaM assigned chemical shift 
Peak # A.a # HN Cα N  Peak # A.a # HN Cα N 
1 G 25 10.354 42.401 112.516  48 M 145 7.47 53.319 114.939 
2 G 98 10.299 42.106 112.074  49 Y 99 7.496 53.669 116.012 
3 G 134 10.039 42.938 112.38  50  7.556 58.947 114.722 
4 G 33 8.694 45.654 105.632  51 G 113 7.742 42.411 107.29 
5 G 61 7.48 42.697 108.13  52 G 40 7.636 42.631 106.794 
6 T 29 9.079 63.992 112.495  53 G 96 7.528 44.156 108.825 
7 T 117 8.93 57.95 113.529  54 G 23 7.502 44.296 108.925 
8 T 44 8.693 57.929 113.057  55 T 62 7.48 56.884 108.13 
9 T 5 8.574 57.674 112.776  56  7.467 44.526 108.306 
10 I 100 9.831 58.597 126.813  56 G 132 7.458 44.352 108.423 
11 I 27 9.768 58.432 126.149  58 F 19 6.977 56.428 112.386 
12 N 137 9.387 48.084 128.895  59  7.15 58.947 114.62 
13 D 64 9.006 49.289 128.6  60 A 57 8.124 51.183 131.498 
14 A 102 9.209 53.063 122.898  61 I 130 8.168 60.568 128.09 
15 K 13 8.925 57.151 122.912  62 L 116 8.002 51.402 125.255 
16 E 6 8.873 57.748 120.252  63 K 148 7.803 54.764 126.002 
17 R 106 8.882 57.436 118.96  64 K 94 7.67 55.728 125.575 
18 S 101 8.87 53.177 123.812  65 A 147 7.594 50.088 126.583 
19 V 136 8.855 58.684 124.898  66 K 21 7.52 55.64 124.285 
20 F 65 8.764 60.166 118.898  67 N 111 7.907 52.924 123.876 
21 D 118 8.756 55.18 120.864  68 A 15 8.117 52.76 123.8 
22 E 45 8.68 57.315 120.304  69 V 121 8.072 58.443 123.213 
23 
 
8.715 55.503 120.047  70  8.191 51.731 123.212 
24 
 
8.664 56.1 119.522  70 L 4 7.481 51.717 120.921 
25 
 
7.575 57.191 121.362  71 K 115 8.378 52.903 124.176 
25 
 
8.537 57.191 119.657  72 I 63 8.447 57.819 122.6 
26 
 
8.517 51.939 120.428  73  7.695 52.669 118.387 
27 E 119 8.504 57.13 119.095  73  8.282 52.669 122.572 
28 V 142 8.484 64.225 118.546  74  8.208 56.841 121.987 
29 F 16 8.445 58.991 118.968  75 L 105 8.301 55.662 121.476 
30 
 
8.421 59.509 119.249  76 D 24 8.314 50.988 120.787 
31 
 
8.691 63.896 117.008  77  8.413 51.917 120.251 
32 N 42 8.558 48.61 115.871  78  8.321 51.797 119.97 
33 M 36 7.975 55.157 115.68  79  8.241 55.334 120.05 
33 N 53 8.485 56.585 117.299  80  8.196 52.673 119.803 
34 
 
8.378 61.378 114.327  81  8.222 51.698 120.783 
35 T 28 8.306 56.943 116.306  81 L 39 7.121 54.745 120.228 
36 
 
8.282 56.833 122.572  82 D 133 8.182 50.822 120.481 
36 
 
8.331 56.833 118.259  83 A 46 8.16 52.298 120.793 
37 
 
8.196 52.979 117.391  84  7.952 52.662 121.545 
38 D 131 8.14 51.36 116.474  85 A 103 8.151 52.465 118.719 
39 D 58 8.129 49.946 114.225  86 N 60 8.094 49.88 118.727 
40 T 26 8.015 56.932 111.799  87 D 50 7.991 56.867 118.54 
41 
 
7.94 50.231 113.981  88  7.924 57.502 118.514 
42 D 22 7.816 50.034 113.714  89 M 51 7.891 56.724 118.106 
43 S 17 7.875 58.969 114.684  90  7.977 54.688 117.142 
45 Q 135 7.865 50.472 115.578  91 D 93 7.957 49.837 117.212 
46 
 
7.786 57.94 115.757  92  7.842 56.297 117.493 
47 
 






Appendix D continued-CaM assigned chemical shift 
Peak # A.a # HN Cα N  Peak # A.a # HN Cα N 
94 Q 41 7.806 50.844 118.284  156  8.18 57.813 120.69 
95 
 
7.695 56.702 118.387  158  7.922 51.41 125.018 
96 
 
7.67 61.159 117.544  160  7.925 54.696 113.887 
97 
 
7.701 61.663 116.906  160  7.925 63.933 113.887 
98 Q 49 7.962 57.031 119.657  161  7.931 57.776 118.47 
99 
 
7.909 54.917 119.638       
100 
 
7.896 64.137 120.48       
101 E 114 7.847 51.489 120.065       
102 
 
7.81 56.797 119.647       
103 
 
7.758 54.808 120.104       
104 E 14 7.499 56.439 120.078       
104 L 48 7.794 56.575 120.144       
106 E 47 7.554 56.449 118.6       
107 
 
7.489 56.574 118.675       
108 
 
7.421 64.214 118.683       
109 D 129 7.507 51.665 117.839       
110 D 20 7.437 49.552 117.181       
111 
 
7.392 55.859 117       
112 E 54 7.324 55.377 116.72       
113 
 
7.293 56.209 116.141       
114 
 
7.261 55.979 116.463       
115 A 128 7.109 48.194 117       
116 
 
7.325 51.424 117.94       
117 
 
7.262 63.371 118.698       
118 
 
7.114 56.144 119.488       
120 L 18 7.186 54.742 120.209       
121 
 
6.882 40.2 119.817       
122 
 
7.33 47.338 120.621       
122 K 30 7.472 56.516 120.713       
125 
 
7.575 56.591 121.362       
126 V 35 7.27 64.334 121.515       
127 
 
7.854 54.928 126.32       
128 
 
8.385 57.841 122.541       
129 
 
8.222 59.654 117.211       
130 
 
7.724 50.603 127.424       
131 N 97 8.214 49.722 119.448       
135 Y 138 8.072 59.853 118.571       
138 
 
8.662 54.753 119.602       
139 
 
7.806 56.86 119.512       
140 
 
8.154 54.741 118.825       
141 
 
7.806 59.815 119.348       
142 
 
7.615 52.86 119.333       
142 L 112 7.627 52.917 119.231       
145 
 
8.379 59.085 123.754       
147 
 
7.334 47.246 120.426       
150 
 
7.836 51.489 120.086       
151 T 146 7.545 59.203 108.69       
153 
 
8.188 51.745 123.092       
155 
 
6.696 57.24 112.56       
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